<SEC-DOCUMENT>0001193125-23-058966.txt : 20230303
<SEC-HEADER>0001193125-23-058966.hdr.sgml : 20230303
<ACCEPTANCE-DATETIME>20230303070404
ACCESSION NUMBER:		0001193125-23-058966
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230301
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230303
DATE AS OF CHANGE:		20230303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		23701618

	BUSINESS ADDRESS:	
		STREET 1:		5 BAZEL ST
		STREET 2:		P O B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
		BUSINESS PHONE:		9729267267

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		5 BAZEL ST PO B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d422149d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://www.tevapharm.com/20230301" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-03-01_to_2023-03-01">TEVA PHARMACEUTICAL INDUSTRIES LTD</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-03-01_to_2023-03-01">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-03-01_to_2023-03-01">0000818686</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="teva-20230301.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-03-01_to_2023-03-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-03-01</xbrli:startDate> <xbrli:endDate>2023-03-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-03-01_to_2023-03-01">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported) <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt:datemonthdayyearen">March 1, 2023</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-03-01_to_2023-03-01">001-16174</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-03-01_to_2023-03-01">00-0000000</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other Jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Incorporation Or Organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification Number)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-03-01_to_2023-03-01">124 Dvora Hanevi&#8217;a Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-03-01_to_2023-03-01">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-03-01_to_2023-03-01">6944020</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, including Zip Code)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-03-01_to_2023-03-01">972</ix:nonNumeric><span style="white-space:nowrap">-</span> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-03-01_to_2023-03-01">3-914-8213</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name, former address and former fiscal year, if changed since last report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of each&#160;class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which&#160;registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-03-01_to_2023-03-01">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-03-01_to_2023-03-01">TEVA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">((&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging Growth Company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-03-01_to_2023-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD&#160;Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 1, 2023, Teva Pharmaceutical Industries Limited (the &#8220;Company&#8221;) issued a press release announcing the pricing of the Securities (as defined below). A copy of the related press release issued by the Company is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein in its entirety. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 hereto is being furnished to the Securities and Exchange Commission (the &#8220;Commission&#8221;) and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) nor shall it be deemed incorporated by reference in any filing made by the Company under the&#160;Securities Act&#160;or the Exchange Act, except as set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"></span>Item&#160;8.01</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Other Events<span style="font-weight:bold"> </span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 1, 2023, Teva Pharmaceutical Finance Netherlands II B.V. (&#8220;Teva Finance II&#8221;), Teva Pharmaceutical Finance Netherlands III B.V. (&#8220;Teva Finance III&#8221; and together with Teva Finance II, the &#8220;Issuers&#8221;) and, the Company, as guarantor, entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Citigroup Global Markets Europe AG, Citigroup Global Markets Inc., Goldman Sachs Bank Europe SE, Mizuho Securities Europe GMBH, Mizuho Securities USA LLC, MUFG Securities (Europe) N.V., MUFG Securities Americas Inc. and PNC Capital Markets LLC, as representatives for the underwriters named in Schedule 1 annexed thereto (the &#8220;Underwriters&#8221;), providing for the offer and sale by Teva Finance II of &#8364;800,000,0000&#160;aggregate principal amount of 7.375% Sustainability-Linked Senior Notes due 2029 (the &#8220;2029 Euro Notes&#8221;) and &#8364;500,000,000&#160;aggregate principal amount of 7.875% Sustainability-Linked Senior Notes due 2031 (the &#8220;2031 Euro Notes&#8221;) and providing for the offer and sale by Teva Finance III of $600,000,000&#160;aggregate principal amount of 7.875% Sustainability-Linked Senior Notes due 2029 (the &#8220;2029 USD Notes&#8221;) and $500,000,000 aggregate principal amount of 8.125% Sustainability-Linked Senior Notes due 2031 (the &#8220;2031 USD Notes&#8221; and, together with the 2029 USD Notes, the 2029 Euro Notes and the 2031 Euro Notes, the &#8220;Securities&#8221;). The sale of the Securities is expected to close on March&#160;9, 2023. The offering of the 2029 Euro Notes was priced at 100.00% of the &#8364;800,000,000&#160;principal amount of the 2029 Euro Notes to be issued. The offering of the 2031 Euro Notes was priced at 100.00% of the &#8364;500,000,000 principal amount of the 2031 Euro Notes to be issued. The offering of the 2029 USD Notes was priced at 100.00% of the $600,000,000&#160;principal amount of the 2029 USD Notes to be issued. The offering of the 2031 USD Notes was priced at 100.00% of the $500,000,000&#160;principal amount of the 2031 USD Notes to be issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of the Securities was registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and is being made pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR</span> (File No.&#160;333-260519) and the prospectus included therein (the &#8220;Registration Statement&#8221;), filed by the Company with the Commission on October&#160;27, 2021, and the prospectus supplement relating thereto, dated February&#160;27, 2023, and filed with the Commission on February&#160;27, 2023 pursuant to Rule 424(b)(5) promulgated under the Securities Act. The Underwriting Agreement contains customary representations, warranties and covenants of the Company and the Issuers. It also provides for customary indemnification by each of the Company, the Issuers and the Underwriters against certain liabilities and customary contribution provisions in respect of those liabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to the copy thereof which is filed herewith as Exhibit&#160;1.1 and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d422149dex11.htm">Underwriting Agreement, dated as of March&#160;1, 2023, among the Issuers, the Company, Citigroup Global Markets Europe AG, Citigroup Global Markets Inc., Goldman Sachs Bank Europe SE, Mizuho Securities Europe GMBH, Mizuho Securities USA LLC, MUFG Securities (Europe) N.V., MUFG Securities Americas Inc. and PNC Capital Markets LLC as representatives for the underwriters named in Schedule 1 annexed thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d422149dex991.htm">Press Release dated March 1, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page of this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&#160;3, 2023 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:18%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:81%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">TEVA&#160;PHARMACEUTICAL&#160;INDUSTRIES&#160;LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Eli Kalif</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Chief Financial Officer</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d422149dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#128;800,000,000 7.375% Sustainability-Linked Senior Notes due 2029 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#128;500,000,000 7.875% Sustainability-Linked Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$600,000,000 7.875% Sustainability-Linked Senior Notes due 2029 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$500,000,000 8.125% Sustainability-Linked Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of principal and interest unconditionally guaranteed by </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL INDUSTRIES LIMITED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;1, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets
Europe AG </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs Bank Europe SE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities
Europe GMBH </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">MUFG Securities (Europe) N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Euro Representatives
(as defined herein) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Europe AG</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reuterweg 16</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">60323 Frankfurt am Main</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Germany</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs Bank Europe SE</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marienturm</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taunusanlage <FONT STYLE="white-space:nowrap">9-10</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">D-60329</FONT> Frankfurt am Main</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Germany</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities Europe GmbH</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taunustor 1</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">60310 Frankfurt am Main</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Germany</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities (Europe) N.V.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">World Trade Center</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tower H, 11th Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zuidplein 98</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1077 XV Amsterdam</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Netherlands</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10th Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">300 Fifth Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pittsburgh, Pennsylvania 15222</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To: the other Euro Underwriters (as defined herein) listed in Part A of Schedule I hereto
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs
Bank Europe SE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">MUFG Securities Americas Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC Capital
Markets LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Dollar Representatives (as defined herein) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">388 Greenwich Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10013</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs Bank Europe SE</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marienturm</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taunusanlage <FONT STYLE="white-space:nowrap">9-10</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">D-60329</FONT> Frankfurt am Main</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Germany</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1271 Avenue of the Americas</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10020</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1221 Avenue of the Americas</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10020-1001</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10th Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">300 Fifth Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pittsburgh, Pennsylvania 15222</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To: the other Dollar Underwriters (as defined herein) listed in Part B of Schedule I hereto </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Teva Pharmaceutical Finance Netherlands II B.V. (the &#147;<B><U>Euro Notes Issuer</U></B>&#148;), a private company with
limited liability (<I>besloten vennootschap met beperkte </I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
<I>aansprakelijkheid</I>) organized under the laws of the Netherlands and an indirect wholly-owned subsidiary of Teva Pharmaceutical Industries Limited, a company organized under the laws of
Israel (the &#147;<B><U>Guarantor</U></B>&#148;), proposes, subject to the terms and conditions stated herein, to issue and sell &#128;800,000,000 in aggregate principal amount of its 7.375% Sustainability-Linked Senior Notes due 2029 (the
&#147;<B><U>2029 Euro Notes</U></B>&#148;) and &#128;500,000,000 in aggregate principal amount of its 7.875% Sustainability-Linked Senior Notes due 2031 (the &#147;<B><U>2031 Euro Notes</U></B>&#148; and, together with the 2029 Euro Notes, the
&#147;<B><U>Euro Notes</U></B>&#148;), which Euro Notes are to be guaranteed by the Guarantor (the &#147;<B><U>Euro Guarantees</U></B>&#148; and, together with the Euro Notes, the &#147;<B><U>Euro Securities</U></B>&#148;), to the underwriters named
in Part A of Schedule I hereto (individually, each a &#147;<B><U>Euro Underwriter</U></B>&#148; and, collectively, the &#147;<B><U>Euro Underwriters</U></B>&#148;), for whom Citigroup Global Markets Europe AG, Goldman Sachs Bank Europe SE, Mizuho
Securities Europe GMBH, MUFG Securities (Europe) N.V. and PNC Capital Markets LLC are acting as representatives (the &#147;<B><U>Euro Representatives</U></B>&#148;). Teva Pharmaceutical Finance Netherlands III B.V. (the &#147;<B><U>Dollar Notes
Issuer</U></B>&#148; and, together with the Euro Notes Issuer, the &#147;<B><U>Issuers</U></B>&#148;), a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) organized under the laws of the Netherlands
and an indirect wholly-owned subsidiary of the Guarantor, proposes, subject to the terms and conditions stated herein, to issue and sell $600,000,000 in aggregate principal amount of its 7.875% Sustainability-Linked Senior Notes due 2029 (the
&#147;<B><U>2029 Dollar Notes</U></B>&#148;) and $500,000,000 in aggregate principal amount of its 8.125% Sustainability-Linked Senior Notes due 2031 (the &#147;<B><U>2031 Dollar Notes</U></B>&#148; and, together with the 2029 Dollar Notes, the
&#147;<B><U>Dollar Notes</U></B>&#148; and, together with the Euro Notes, the &#147;<B><U>Notes</U></B>&#148;), which Dollar Notes are to be guaranteed by the Guarantor (the &#147;<B><U>Dollar Guarantees</U></B>&#148; and, together with the Dollar
Notes, the &#147;<B><U>Dollar Securities</U></B>&#148; and, the Dollar Guarantees together with the Euro Guarantees, the &#147;<B><U>Guarantees</U></B>&#148; and, the Dollar Securities together with the Euro Securities, the
&#147;<B><U>Securities</U></B>&#148;), to the underwriters named in Part B of Schedule I hereto (individually, each a &#147;<B><U>Dollar Underwriter</U></B>&#148; and collectively, the &#147;<B><U>Dollar</U></B><B>
</B><B><U>Underwriters</U></B>&#148; and, together with the Euro Underwriters, the &#147;<B><U>Underwriters</U></B>&#148; and each individually an &#147;<B><U>Underwriter</U></B>&#148;), for whom Citigroup Global Markets Inc., Goldman Sachs Bank
Europe SE, Mizuho Securities USA LLC, MUFG Securities Americas Inc. and PNC Capital Markets LLC are acting as representatives (the &#147;<B><U>Dollar Representatives</U></B>&#148; and, together with the Euro Representatives, the
&#147;<B><U>Representatives</U></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Euro Securities will be issued pursuant to an indenture, dated as of
March 14, 2018 (such indenture, the &#147;<B><U>Existing Euro Notes Indenture</U></B>&#148;), to be supplemented by a fourth supplemental indenture to be dated as of the Delivery Date (the &#147;<B><U>Supplemental Euro Notes</U></B><B>
</B><B><U>Indenture</U></B>&#148;), among the Euro Notes Issuer, the Guarantor, The Bank of New York Mellon, as trustee (the &#147;<B><U>Trustee</U></B>&#148;) and The Bank of New York Mellon, London Branch, as principal paying agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Dollar Securities will be issued pursuant to an indenture, dated as of March&nbsp;14, 2018 (such indenture, the
&#147;<B><U>Existing Dollar Notes Indenture</U></B>&#148; and, together with the Existing Euro Notes Indenture, the &#147;<B><U>Existing Indentures</U></B>&#148;), to be supplemented by a fourth supplemental indenture to be dated as of the Delivery
Date (as defined in Section&nbsp;2(a)) (the &#147;<B><U>Supplemental Dollar Notes Indenture</U></B>&#148; and, together with the Supplemental Euro Notes Indenture, the &#147;<B><U>Supplemental Indentures</U></B>&#148; and, the Supplemental
Indentures together with the Existing Indentures, the &#147;<B><U>Indentures</U></B>&#148; and each individually an &#147;<B><U>Indenture</U></B>&#148;), among the Dollar Notes Issuer, the Guarantor and the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Underwriters have advised the Issuers and the Guarantor that they will offer and sell the Securities purchased from the
Issuers and the Guarantor hereunder in accordance with Section&nbsp;2 of this Agreement as soon as they deem advisable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Agreement, the Indentures and the Notes are referred to herein
collectively as the &#147;<B><U>Operative Documents</U></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any reference herein to the Registration Statement,
the Prospectus and the Preliminary Prospectus shall be deemed to refer to and include the Incorporated Documents as of the Effective Time of the Registration Statement or the issue date of such Prospectus or Preliminary Prospectus, respectively, and
any reference herein to the terms &#147;amend,&#148; &#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, the Prospectus and the Preliminary Prospectus shall be deemed to refer to and include the filing of any
document under the Securities Exchange Act of 1934, as amended (the &#147;<B><U>Exchange Act</U></B>&#148;), after the Effective Time of the Registration Statement or the issue date of the Prospectus or Preliminary Prospectus, respectively, deemed
to be incorporated therein by reference. Certain capitalized terms used herein are defined in Section&nbsp;22. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This is to
confirm the agreement between the Issuers, the Guarantor and the Underwriters concerning the issue, offer and sale of the Securities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Representations, Warranties and Agreements of the Issuers and the Guarantor.</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Issuers (except for the representation in Section&nbsp;1(ll), which is given by the Euro
Notes Issuer only) and the Guarantor, jointly and severally, represent, warrant to and agree with, the Underwriters that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) The Registration Statement, setting forth information with respect to the Issuers, the Guarantor and the
Securities is an automatic shelf registration statement as defined in Rule 405 of the rules and regulations of the Securities and Exchange Commission (the &#147;<B><U>Commission</U></B>&#148;) under the Securities Act (the &#147;<B><U>Rules and
Regulations</U></B>&#148;). The Registration Statement, including the Base Prospectus, has (i)&nbsp;been prepared by the Issuers and the Guarantor in conformity in all material respects with the requirements of the Securities Act of 1933, as amended
(the &#147;<B><U>Securities Act</U></B>&#148;), (ii) been filed with the Commission under the Securities Act and (iii)&nbsp;become effective upon filing under the Securities Act. The Issuers and the Guarantor have included in such Registration
Statement, as amended at the Effective Time, all information required by the Securities Act and the rules thereunder to be included in such Registration Statement and the Base Prospectus. The Issuers may have filed with the Commission a Preliminary
Prospectus pursuant to Rule 424(b) of the Rules and Regulations, which has previously been furnished to the Underwriters. The Issuers and the Guarantor will file with the Commission the Prospectus in accordance with Rule 424(b) of the Rules and
Regulations. As filed, such Prospectus will contain all information required by the Securities Act and the Rules and Regulations, and, except to the extent the Representatives will agree in writing to a modification, will be in all substantial
respects in the form furnished to the Underwriters prior to the Execution Time, or, to the extent not completed at the Execution Time, shall contain only such additional information and other changes as the Issuers and Guarantor have advised the
Underwriters, prior to the Execution Time, will be included or made therein or such changes as are made after consulting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with the Underwriters or their counsel. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The
conditions for use of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> as set forth in the general instructions thereto, have been satisfied or waived. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The Registration Statement conforms, and the Prospectus and any further amendments or supplements to the
Registration Statement or the Prospectus will, when they are filed with the Commission, conform in all material respects to the requirements of the Securities Act and the Trust Indenture Act of 1939, as amended (the &#147;<B><U>Trust Indenture
Act</U></B>&#148;). The Registration Statement and any amendment thereto did not, as of the Effective Time and at the Execution Time, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Prospectus does not and will not, as of the date thereof and on the Delivery Date, contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, it being understood that none of the Issuers
or the Guarantor makes any representation or warranty as to (i)&nbsp;information contained in or omitted from the Registration Statement or the Prospectus in reliance upon and in conformity with written information furnished to the Issuers and the
Guarantor by the Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e) and (ii)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility and
Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust Indenture Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) The Incorporated Documents as amended or supplemented at the date hereof, when they were filed with the
Commission, conformed in all material respects to the requirements of the Securities Act and the Exchange Act. None of the Incorporated Documents as amended or supplemented at the date hereof, when such documents were filed with the Commission,
contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Any
further documents so filed and incorporated by reference in the Prospectus, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) (i) The Disclosure Package, when taken together as a whole, and (ii)&nbsp;each electronic road show, when
taken together as a whole with the Disclosure Package, as of the Execution Time, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to information contained in or omitted from the Disclosure Package or in any
electronic road show in reliance upon and in conformity with written information furnished to the Issuers and the Guarantor by the Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) (i) At the time of filing the Registration Statement, (ii)&nbsp;at the time of the most recent
amendment thereto, if any, for the purposes of complying with Section&nbsp;10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or 15(d) of the Exchange Act or form
of prospectus), (iii) at the time the Issuers and the Guarantor or any person acting on their behalf (within the meaning, for this clause only, of Rule 163(c) of the Rules and Regulations) made any offer relating to the Securities in reliance on the
exemption in Rule 163 of the Rules and Regulations, and (iv)&nbsp;at the Execution Time (with such date being used as the determination date for purposes of this clause (iv)), the Guarantor was or is (as the case may be) a &#147;well-known seasoned
issuer&#148; as defined in Rule 405 of the Rules and Regulations. The Issuers and the Guarantor agree to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) of the Rules and Regulations
without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) (i) At the earliest time after the filing of the Registration Statement that the Issuers or the Guarantor
or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Rules and Regulations) of the Securities and (ii)&nbsp;as of the Execution Time (with such date being used as the determination date for purposes of
this clause (ii)), the Issuers and the Guarantor were not and are not Ineligible Issuers (as defined in Rule 405 of the Rules and Regulations), without taking account of any determination by the Commission pursuant to Rule 405 of the Rules and
Regulations that it is not necessary that either the Issuers or the Guarantor be considered an Ineligible Issuer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) Each Issuer Free Writing Prospectus and the final term sheet prepared and filed pursuant to
Section&nbsp;3(c) hereto do not include any information that conflicts with the information contained in the Registration Statement, including the Incorporated Documents and the Preliminary Prospectus and the Prospectus deemed to be a part thereof
that has not been superseded or modified. The preceding sentence does not apply to information contained in or omitted from the Disclosure Package in reliance upon and in conformity with written information furnished to the Issuers and the Guarantor
by the Representatives, on behalf of the Underwriters, specifically for inclusion therein as provided in Section&nbsp;7(e). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) Each of the Issuers and the Guarantor have not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
engaged in any form of solicitation, advertising or other action constituting an offer or a sale under the Israeli Securities Law 5728-1968, as amended (the &#147;<B><U>Israeli Securities
Law</U></B>&#148;), and the regulations promulgated thereunder in connection with the offer and sale of the Securities contemplated hereby, other than offering Securities solely to qualified investors of the type listed on the First Addendum to the
Israeli Securities Law, and, assuming the Underwriters&#146; compliance with Section&nbsp;6(f) hereof, are not required to publish a prospectus in Israel with respect to the offer and sale of the Securities contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) Each of the Guarantor and each &#147;significant subsidiary&#148; of the Guarantor (as such term is defined
in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X)</FONT> (each, a &#147;<B><U>Significant Subsidiary</U></B>&#148; and, collectively, the &#147;<B><U>Significant Subsidiaries</U></B>&#148;)
has been duly organized and is validly existing in good standing (in all jurisdictions in which such concept is relevant) under the laws of the jurisdiction in which it is chartered or organized, is duly qualified to do business and is in good
standing as a foreign corporation in each jurisdiction in which its ownership or lease of property or the conduct of its business requires such qualification (except for where the failure to be so qualified would not have a material adverse effect
on the business, properties, financial condition, results of operations or prospects of the Guarantor and its subsidiaries, taken as a whole, except as set forth in or contemplated in each of the Disclosure Package and the Prospectus (exclusive of
any amendment or supplement thereto) (a &#147;<B><U>Material Adverse Effect</U></B>&#148;)), and has all corporate power and authority necessary to own or hold its properties and to conduct its business as described in each of the Disclosure Package
and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(k) Each of the Issuers has been duly organized and is validly existing as a private
company with limited liability (<I>besloten</I><I> </I><I>vennootschap</I><I> met </I><I>beperkte</I><I> </I><I>aansprakelijkheid</I>) under the laws of the Netherlands, is qualified to do business and is in good standing as a foreign corporation in
each jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such qualification (except for where the failure to be so qualified would not have a Material Adverse Effect), and has all corporate power and
authority necessary to own or hold its properties and to conduct its businesses as described in each of the Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(l) All of the outstanding shares of capital stock of each Significant Subsidiary of the Guarantor have been
duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise set forth in each of the Disclosure Package and the Prospectus, all outstanding shares of capital stock of such subsidiaries are owned by the
Guarantor either directly or through wholly-owned subsidiaries free and clear of any perfected security interest or any other security interests, claims, liens or encumbrances. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(m) All of the outstanding shares of capital stock of each of the Issuers have been duly authorized and validly
issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and were not issued in violation of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
preemptive or similar rights granted pursuant to the organizational documents of each of the Issuers or any statutory provisions of Dutch law, and all outstanding shares of each of the Issuers
are owned by the Guarantor either directly or through wholly-owned subsidiaries free and clear of any perfected security interest or any other security interests, claims, liens or encumbrances. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(n) The Guarantor has an authorized capitalization as set forth in each of the Disclosure Package and the
Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(o) The statements contained in each of the Preliminary Prospectus under the caption
&#147;Description of the Euro Notes and the Guarantees&#148; and &#147;Description of the USD Notes and the Guarantees,&#148; as supplemented by the final term sheet prepared and filed pursuant to Section&nbsp;3(c) hereof, insofar as they purport to
summarize the provisions of the Indentures and the Securities, are accurate and complete in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(p) Neither the execution, delivery and performance of this Agreement and the other Operative Documents by the
applicable Issuer and the Guarantor, nor the issuance of the Securities under this Agreement will (x)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage,
deed of trust, loan agreement or other agreement or instrument to which such Issuer or the Guarantor is a party or by which such Issuer or the Guarantor is bound or to which any of the properties or assets of such Issuer or the Guarantor is subject,
except for any conflict, breach or violation that would not have, individually or in the aggregate, a Material Adverse Effect, (y)&nbsp;result in any violation of the provisions of the memorandum of association or the articles of association of the
Guarantor or the organizational documents of such Issuer or (z)&nbsp;result in any violation in any material respect of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the applicable
Issuer or the Guarantor or any of their respective properties or assets; and except (i)&nbsp;such as have been or will be obtained under the Securities Act, the Trust Indenture Act and the rules and regulations promulgated thereunder, (ii)&nbsp;as
may be required by the securities or &#147;blue sky&#148; laws of any state of the United States, (iii)&nbsp;as may be required under the applicable laws of the Netherlands, (iv)&nbsp;for the filing or furnishing of public announcements in
connection with the issue and offer of the Securities with the Commission, the New York Stock Exchange, the Israel Securities Authority, the Tel Aviv Stock Exchange and the Israeli Companies Registrar that may be required to be made on or after the
date of this Agreement and the Closing Date, as applicable, and (v)&nbsp;with respect to the Euro Notes only, as may be required under the rules and regulations of the Euronext Dublin with respect to the listing thereon of the Euro Notes, no
consent, approval, authorization or order of, or filing or registration with, any such court or governmental agency or body is required for the execution, delivery and performance of the Operative Documents by each of the Issuers and the Guarantor,
and the consummation of the offer and sale of the Securities contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(q) Each of the Issuers and the Guarantor has all necessary
corporate right, power and authority to execute and deliver this Agreement and perform its obligations hereunder; and this Agreement, and the offer and sale of the Securities contemplated hereby, have been duly authorized, and this Agreement has
been duly executed and delivered by each of the Issuers and the Guarantor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(r) Each of the Issuers and the
Guarantor has all necessary corporate right, power and authority to execute and deliver each of the Supplemental Indentures to which it is party and perform its obligations thereunder; each of the Supplemental Indentures has been duly authorized by
the Issuer party thereto and the Guarantor, and on the Delivery Date, each of the Supplemental Indentures which will be qualified under the Trust Indenture Act and will have been duly executed and delivered by the Issuer party thereto and the
Guarantor and, assuming due authorization, execution and delivery of each of the Supplemental Indentures by the Trustee and (in the case of the Supplemental Euro Notes Indenture) the principal paying agent party thereto, will constitute a legally
valid and binding agreement of each of the Issuers party thereto and the Guarantor, enforceable against each of the Issuers party thereto and the Guarantor in accordance with its terms, except as the enforceability thereof may be limited by
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting creditors&#146; rights generally, subject to general principles of equity and to limitations on availability of equitable relief,
including specific performance (whether considered in a proceeding in equity or at law) and an implied covenant of good faith and fair dealing (collectively, the &#147;<B><U>Enforceability Exceptions</U></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(s) Each of the Existing Indentures has been duly authorized, executed and delivered by the Issuer party
thereto and the Guarantor, and, assuming due authorization, execution and delivery of each of the Existing Indentures by the Trustee and (in the case of the Existing Euro Notes Indenture) the principal paying agent party thereto, constitutes a
legally valid and binding agreement of each of the Issuers party thereto and the Guarantor, enforceable against each of the Issuers party thereto and the Guarantor in accordance with its terms, except as the enforceability thereof may be limited by
the Enforceability Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(t) Each of the Issuers and the Guarantor has all necessary corporate
right, power and authority to execute, issue and deliver the Notes and Guarantees, respectively, and perform its obligations thereunder; the Notes have been duly authorized by each of the applicable Issuers and the Guarantees have been duly
authorized by the Guarantor; when the Notes are executed, authenticated and issued in accordance with the terms of the applicable Indenture and delivered to and paid for by the Underwriters pursuant to this Agreement on the Delivery Date (assuming
due authentication of the Notes by the Trustee), such Notes will constitute legally valid and binding obligations of each of the applicable Issuers, entitled to the benefits of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the applicable Indenture and enforceable against each of the applicable Issuers in accordance with their terms, except as the enforceability thereof may be limited by the Enforceability
Exceptions; when the Guarantees are executed and issued in accordance with the terms of the applicable Indenture and the Notes on which they are endorsed have been executed in accordance with the applicable Indenture and delivered to and paid for by
the Underwriters pursuant to this Agreement on the Delivery Date, such Guarantees will constitute legally valid and binding obligations of the Guarantor, and enforceable against the Guarantor in accordance with their terms, except as the
enforceability thereof may be limited by the Enforceability Exceptions, and entitled to the benefit of the applicable Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(u) Except as described in each of the Disclosure Package and the Prospectus, there are no contracts,
agreements or understandings between each of the Issuers or the Guarantor and any person granting such person the right (other than rights which have been waived or satisfied) to require the Issuers or the Guarantor to file a registration statement
under the Securities Act with respect to any securities of the Issuers or the Guarantor owned or to be owned by such person or to require the Issuers or the Guarantor to include such securities in any securities being registered pursuant to any
registration statement filed by the Issuers or the Guarantor under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(v) Except as would
not have a Material Adverse Effect, (x)&nbsp;the Guarantor, since the date of the latest audited financial statements incorporated by reference in the Disclosure Package, and (y)&nbsp;each of the Issuers, at any time since its respective formation,
has not sustained any loss or interference with its respective business from fire, explosion, flood or other calamity, whether or not covered by insurance, or, except as described in each of the Disclosure Package and the Prospectus, from any labor
dispute or court or governmental action, order or decree; and (i)&nbsp;with respect to each of the Issuers, since the respective date on which it became a wholly-owned subsidiary of the Guarantor, and (ii)&nbsp;with respect to the Guarantor, since
the date of the most recent audited financial statements incorporated by reference in the Disclosure Package, except for the transactions contemplated hereby or as described in each of the Disclosure Package and the Prospectus, there has not been
any change in such entity&#146;s respective capital stock or long-term debt of each of the Issuers or the Guarantor, or any change or any development including a prospective change that would have a Material Adverse Effect, except for any grants
under the employee stock plans of the Guarantor or its subsidiaries (the &#147;<B><U>Authorized Grants</U></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(w) The consolidated financial statements of the Guarantor (including the related notes and supporting
schedules) incorporated by reference in the Disclosure Package present fairly, in all material respects, the financial condition and results of operations of the Guarantor and its consolidated subsidiaries at the dates and for the periods indicated,
comply as to form in all material respects with the applicable accounting requirements of the Securities Act and the Rules and Regulations and have been prepared in conformity with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
generally accepted accounting principles in the United States applied on a consistent basis throughout the periods involved, subject to, only in the case of the unaudited financial statements,
ordinary <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(x) Kesselman&nbsp;&amp; Kesselman,
who audited the annual financial statements of the Guarantor, incorporated by reference in each of the Disclosure Package and the Prospectus, and whose report is incorporated by reference therein, is the independent registered accounting firm with
respect to the Guarantor within the meaning of the Securities Act and the Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(y)
Except as would not have a Material Adverse Effect and except as disclosed in each of the Disclosure Package and the Prospectus, the Guarantor and its subsidiaries own or possess, or hold valid licenses in respect of, all patents, patent rights,
licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how,</FONT> trade secrets, trademarks, service marks and trade names necessary for the conduct of their respective businesses in the manner described in each of the Disclosure
Package and the Prospectus, and, except as described in each of the Disclosure Package and the Prospectus, the Guarantor has not received any notice of, and has no knowledge of, any infringement of or conflict with asserted rights of others with
respect to any of the foregoing which, singly or in the aggregate, would be reasonably likely to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(z) Each of the Issuers and the Guarantor possesses all certificates, authorizations and permits issued by the
appropriate federal, state or foreign regulatory authorities necessary to conduct its business as now conducted and as described in each of the Disclosure Package and the Prospectus, except for such certificate, authorizations and permits the
failure of which to possess, singly or in the aggregate, would not have a Material Adverse Effect, and neither the Issuers nor the Guarantor have received any notice of proceedings relating to the revocation or modification of any such certificate,
authorization or permit, which singly or in the aggregate, would be reasonably likely to have a Material Adverse Effect, except as described in each of the Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(aa) Except as disclosed in each of the Disclosure Package and the Prospectus, there are no legal or
governmental proceedings pending to which either of the Issuers or the Guarantor or any subsidiary of the Guarantor is a party or of which any property or asset of the Issuers or the Guarantor is the subject which, singly or in the aggregate, would
be reasonably likely to have a Material Adverse Effect; and to the knowledge of each of the Issuers and the Guarantor, no such proceedings are threatened or contemplated by governmental authorities or, except as set forth or contemplated in each of
the Disclosure Package and the Prospectus, threatened by others. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(bb) Each of the Issuers and the
Guarantor is not (i)&nbsp;in violation of its organizational documents, (ii)&nbsp;in default and no event has occurred which, with notice or lapse of time or both, would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii)&nbsp;in violation of any law, ordinance, governmental rule, regulation or court decree to which it or its properties or assets
may be subject or has failed to obtain any license, permit, certificate, franchise or other governmental authorization or permit necessary to the ownership of its properties or to the conduct of its business, except to the extent that any such
default, event or violation described in the foregoing clauses (ii)&nbsp;and (iii) would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(cc) The Guarantor is subject to and in compliance in all material respects with the reporting requirements of
Sections 13 and 15(d) of the Exchange Act and the rules and regulations promulgated under the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(dd) The Guarantor and its subsidiaries (i)&nbsp;are in compliance with any and all applicable foreign,
federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<B><U>Environmental Laws</U></B>&#148;), (ii) have
received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval,
except in each case of clauses (i), (ii) and (iii)&nbsp;where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses
or approvals would not, singly or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ee) Each of the
Guarantor and its subsidiaries, in its reasonable judgment, has concluded that there are no costs or liabilities associated with its respective compliance with Environmental Laws (including, without limitation, any capital or operating expenditures
required for <FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third
parties) which would, singly or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ff) There are no stamp
or other issuance or transfer taxes or duties or other similar fees or charges required to be paid, under Israeli or U.S. federal law or the laws of any U.S. state, by or on behalf of the Underwriters in connection with (A)&nbsp;the issuance, sale
and delivery of the Securities to be sold by the Issuers in the manner contemplated by this Agreement, (B)&nbsp;the sale and delivery by the Underwriters of the Securities as contemplated herein or (C)&nbsp;the execution and delivery of this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(gg) Each of the Issuers and the Guarantor has filed
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
all foreign, national, federal, state and local tax returns that are required to be filed or has requested extensions thereof (except in any case in which the failure so to file would not have a
Material Adverse Effect) and has paid (or withheld) all taxes required to be paid (or withheld) by it and any other assessment, fine or penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such
assessment, fine or penalty that is currently being contested in good faith or as would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(hh) No subsidiary of the Guarantor (other than each of the Issuers) is currently prohibited, directly or
indirectly, from paying any dividends to the Guarantor, from making any other distribution on such subsidiary&#146;s capital stock, from repaying to the Guarantor any loans or advances to such subsidiary from the Guarantor or from transferring any
of such subsidiary&#146;s property or assets to the Guarantor or any other subsidiary of the Guarantor, except as described in or contemplated by each of the Disclosure Package and the Prospectus or except as would not have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) Each of the Issuers and the Guarantor, as of the date hereof and the Closing Date, maintains
a system of internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to
permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific
authorization; and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(jj) Neither of the Issuers nor the Guarantor is an &#147;investment company&#148; or an entity
&#147;controlled&#148; by an &#147;investment company&#148; within the meaning of such term under the Investment Company Act of 1940, as amended (the &#147;<B><U>Investment Company Act</U></B>&#148;), and the rules and regulations of the Commission
thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(kk) Except as disclosed in the Disclosure Package or the Prospectus, payments of interest in
respect of the Securities held by <FONT STYLE="white-space:nowrap">non-Israeli</FONT> residents are not subject to withholding or deduction for or on account of any taxes, duties or other charges of whatever nature imposed by Israel or any authority
thereof or therein having the power to tax. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ll) Application has been made to admit the Euro Notes to the
Official List of Euronext Dublin and trading on the Global Exchange Market and, in connection therewith, the Euro Notes Issuer has caused to be prepared and submitted to Euronext Dublin a listing application with respect to the Euro Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(mm) Neither the Guarantor nor any of its subsidiaries nor any of their respective directors, officers or, to
the knowledge of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Guarantor, any agents, employees or affiliates acting on behalf of the Guarantor or any of its subsidiaries is a person or entity with whom dealings are restricted or prohibited pursuant to
any sanctions administered by the United States (including the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State or the U.S. Department of Commerce) or any sanctions imposed by the United Nations
Security Council, the European Union, His Majesty&#146;s Treasury of the United Kingdom or other relevant sanctions authority, excluding the Arab League (collectively, the &#147;<B><U>Sanctions</U></B>&#148; and each such person or entity, a
&#147;<B><U>Sanctioned Person</U></B>&#148;), nor is the Guarantor or any of its subsidiaries operating, resident or organized under the laws of a country or territory that is the subject of Sanctions that comprehensively prohibit dealings with that
country or territory (which currently comprise Cuba, Iran, Syria, North Korea and the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled parts of Ukraine (including the Crimea Region of Ukraine, the
<FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic, Zaporizhzhia and Kherson) (each, a &#147;<B><U>Sanctioned Country</U></B>&#148;);
and neither of the Issuers nor the Guarantor will directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other
person or entity, for the purpose of financing the activities of or business with: (i)&nbsp;any Sanctioned Person; (ii)&nbsp;any Sanctioned Country except insofar as the relevant conduct is licensed (or is equivalent to that described in published
licenses or authorizations); or (iii)&nbsp;any other activities or services that would give rise to a violation of Sanctions by the Underwriters, the Issuers or the Guarantor. Further, it is acknowledged and agreed that this representation given
pursuant to this Section&nbsp;1(mm) is sought and given if and to the extent that to do so would not result in any violation or breach of any provision of (and in no case may be construed as requiring any party to this Agreement to act in violation
or breach of)&nbsp;(i) Council Regulation (EC) No 2271/96 of 22&nbsp;November 1996, as amended and in force (or any law or regulation implementing such Regulation in any member state of the European Union), or (ii)&nbsp;Council Regulation (EC)
2271/96 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (&#147;<B><U>EUWA</U></B>&#148;) and/or any similar anti-boycott law in the United Kingdom. The representation and undertakings in
this Section&nbsp;1(mm) are only sought by and given to any Underwriter incorporated in or organized under the laws of the Federal Republic of Germany to the extent that to do so would not result in a violation of or a conflict with the German
Foreign Trade Regulation (Au&szlig;enwirtschaftsverordnung) and/or any similar anti-boycott law in Germany. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(nn) Neither the Guarantor nor any of its subsidiaries nor, to the knowledge of the Guarantor, any director,
officer, agent, employee or other person acting on behalf of the Guarantor or any of its subsidiaries, is (i)&nbsp;a person or entity that is organized under the laws of or ordinarily resident in Iran, North Korea or Myanmar, the three jurisdictions
identified by the Financial Action Task Force (&#147;<B><U>FATF</U></B>&#148;) in its October 2022 Public Statement as subject to a FATF call on its members and other jurisdictions (a)&nbsp;to apply enhanced due diligence
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
measures proportionate to the risks arising from the jurisdiction(s), and/or (b)&nbsp;to apply counter-measures to protect the international financial system from the ongoing and substantial
money laundering and financing of terrorism risks emanating from the jurisdiction(s), (each a &#147;<B><U>FATF Public Statement Jurisdiction</U></B>&#148;); or (ii)&nbsp;an entity controlled or majority owned by a person or entity organized under
the laws of or ordinarily resident in a FATF Public Statement Jurisdiction. The Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to
any subsidiary, joint venture partner or other person or entity to fund any activities or business of or with: (i)&nbsp;a FATF Public Statement Jurisdiction, (ii)&nbsp;any person or entity organized under the laws of or ordinarily resident in a FATF
Public Statement Jurisdiction, or (iii)&nbsp;any entity controlled or majority owned by a person or entity organized under the laws of or ordinarily resident in a FATF Public Statement Jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(oo) Except as disclosed in the Guarantor&#146;s consolidated financial statements included in the Disclosure
Package and the Prospectus, neither the Guarantor nor any of its subsidiaries nor, to the knowledge of the Guarantor, any director, officer, agent, employee or affiliate acting on behalf of the Guarantor or any of its subsidiaries has taken any
action, directly or indirectly, that would result in a violation by such persons of the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#147;<B><U>FCPA</U></B>&#148;), the U.K. Bribery Act 2010,
or any other anti-corruption or anti-bribery law or regulation of any other jurisdiction to the extent such other laws or regulations are applicable; and the Guarantor, its subsidiaries and, to the knowledge of the Guarantor, its affiliates have
instituted and maintain policies and procedures reasonably designed to promote and achieve compliance with the FCPA, the U.K. Bribery Act 2010 and any other anti-corruption or anti-bribery law or regulation of any other jurisdiction to the extent
applicable. The Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds directly or indirectly in violation of the FCPA, the U.K. Bribery
Act 2010, or any other anti-corruption or anti-bribery law or regulation of any other jurisdiction to the extent such other laws or regulations are applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(pp) The operations of each of the Guarantor and its subsidiaries are and have been conducted at all times in
compliance in all material respects with applicable financial recordkeeping and reporting requirements, including those of the U.S. Currency and Foreign Transactions Reporting Act of 1970, the Money Laundering, Terrorist Financing and Transfer of
Funds (Information on the Payer) Regulations 2017, as in force, as well as all applicable money laundering statutes of all jurisdictions where each of the Guarantor and its subsidiaries conducts business, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines issued, administered or enforced by any governmental or regulatory agency (collectively, &#147;<B><U>Anti-Money Laundering Laws</U></B>&#148;) and no action, suit or proceeding by or before any
court or governmental or regulatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
agency, authority or body or any arbitrator involving the Guarantor or any of its subsidiaries with respect to Anti-Money Laundering Laws is pending or, to the best of the Guarantor&#146;s
knowledge, threatened. The Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds in any way not in compliance with Anti-Money Laundering
Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(qq) None of the Guarantor or any of its affiliates has taken, directly or indirectly, any action
designed to cause or result in, or which has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Issuers in connection with the offering of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(rr) To the extent that information is required to be publicly disclosed under&#151;Regulation (EU) No 596/2014
on market abuse, as amended and in force and any applicable delegated regulations thereunder, including, without limitation, Commission Delegated Regulation of 8&nbsp;March 2016 supplementing Regulation (EU) 596/2014 with regard to regulatory
technical standards for the conditions applicable to <FONT STYLE="white-space:nowrap">buy-back</FONT> programmes and stabilisation measures (the &#147;<B><U>Stabilising</U></B><B><U> Rules</U></B>&#148;) before stabilising transactions can be
undertaken in compliance with the safe harbor provided under such Stabilising Rules, such information has been adequately publicly disclosed (within the meaning of the Stabilising Rules). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ss) The interactive data in the eXtensible Business Reporting Language (&#147;<B><U>XBRL</U></B>&#148;)
included or incorporated by reference to the Registration Statement, fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(tt) Except as otherwise disclosed in the Disclosure Package, or as would not reasonably be expected to have a
Material Adverse Effect, (i)&nbsp;to the knowledge of the Guarantor, since January&nbsp;1, 2020, there has been no security breach, unauthorized access or disclosure, or other compromise of the Issuers&#146;, the Guarantor&#146;s, nor their
respective subsidiaries&#146; owned or licensed information technology and computer systems, networks, hardware, software, confidential data and databases (including the confidential data and information of their respective customers, employees,
suppliers, vendors and any confidential third party data, in each case, maintained, processed or stored by the Issuers, the Guarantor, or their respective subsidiaries, and any such data processed or stored by third parties on behalf of the Issuers,
the Guarantor, or their respective subsidiaries), or equipment (collectively, &#147;<B><U>IT Systems and Data</U></B>&#148;); (ii) neither the Issuers, the Guarantor, nor their respective subsidiaries have, since January&nbsp;1, 2020, been notified
in writing of, and each of them have no knowledge of any event or condition that would reasonably be expected to result in, any security breach, unauthorized access or disclosure, or other compromise to their IT Systems and Data; and (iii)&nbsp;the
Issuers, the Guarantor and their respective subsidiaries are presently in material compliance with all applicable laws or statutes and all applicable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies of the Issuers, the Guarantor and their respective subsidiaries and
contractual obligations to which the Issuers, the Guarantor and their respective subsidiaries are bound, in each case, to the extent relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from
unauthorized use, access, misappropriation or modification. Except as otherwise disclosed in the Disclosure Package or as would not reasonably be expected to have a Material Adverse Effect, the Issuers, the Guarantor and their respective
subsidiaries have implemented commercially reasonable or appropriate controls, policies, procedures, and technological safeguards designed to maintain and protect the integrity, continuous operation and security of their IT Systems and Data. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Purchase, Sale and Delivery of Securities.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Subject to the terms and conditions and in reliance upon the representations and warranties herein set
forth, (x)&nbsp;the Euro Notes Issuer agrees (and the Guarantor agrees to cause the Euro Notes Issuer) to issue and sell to each Euro Underwriter, and each Euro Underwriter agrees, severally and not jointly, to purchase from the Euro Notes Issuer
(i)&nbsp;at a purchase price of 99.400% of the principal amount thereof, the respective principal amount of the 2029 Euro Notes and (ii)&nbsp;at a purchase price of 99.400% of the principal amount thereof, the respective principal amount of the 2031
Euro Notes, in each case such principal amount Euro Notes as set forth opposite such Euro Underwriter&#146;s name in Part A of Schedule I hereto, and (y)&nbsp;the Dollar Notes Issuer agrees (and the Guarantor agrees to cause the Dollar Notes Issuer)
to issue and sell to each Dollar Underwriter, and each Dollar Underwriter agrees, severally and not jointly, to purchase from the Dollar Notes Issuer (i)&nbsp;at a purchase price of 99.400% of the principal amount thereof, the respective principal
amount of the 2029 Dollar Notes and (ii)&nbsp;at a purchase price of 99.400% of the principal amount thereof, the respective principal amount of the 2031 Dollar Notes, in each case such principal amount of Dollar Notes as set forth opposite such
Dollar Underwriter&#146;s name in Part B of Schedule I hereto. The aggregate amount due to the Euro Notes Issuer from the sale of the Euro Notes is hereinafter referred to as the &#147;<U>euro purchase price</U>,&#148; and the aggregate amount due
to the Dollar Notes Issuer from the sale of the Dollar Notes is hereinafter referred to as the &#147;<U>dollar</U> <U>purchase price</U>.&#148; Reference is hereby made to that certain dealer manager agreement dated February&nbsp;27, 2023 between
certain of the Representatives (and/or their affiliates) and the Guarantor pursuant to which the Guarantor has agreed to pay the dealer managers thereunder a fee of $2 for each $1,000, or &#128;2 for each &#128;1,000, as applicable, in principal
amount of notes acquired pursuant to the tender offer referenced therein (the &#147;<B><U>Tender Fee</U></B>&#148;). The Representatives severally agree to distribute the Tender Fee (net of any expenses or other costs) on a <I>pro rata </I>basis
among the Underwriters in proportion of the total aggregate principal amount of Securities set opposite the name of each Underwriter in Schedule I hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Delivery of and payment for the Euro Securities shall be made at 9:00 a.m. (London time) on March&nbsp;9, 2023 and delivery of and payment for the Dollar Securities shall be made at 9:30 a.m.
(New York time) on March&nbsp;9, 2023, or such later date as the Representatives shall designate (the &#147;<B><U>Closing</U></B><B><U> </U></B><B><U>Date</U></B>&#148;), which date and time may be postponed by agreement among the Representatives,
the Guarantor and each of the Issuers or as provided in Section&nbsp;8 (such date and time of delivery and payment for the Securities being herein called the &#147;<B><U>Delivery Date</U></B>&#148;). Delivery of (i)&nbsp;the Euro Securities shall be
made to Citigroup Global Markets Europe AG on behalf of the Euro Underwriters against payment of the euro purchase price by Citigroup Global Markets Europe AG on behalf of the Euro Underwriters, and (ii)&nbsp;the Dollar Securities shall be made to
Goldman Sachs Bank Europe SE on behalf of the Dollar Underwriters against payment of the dollar purchase price by Goldman Sachs Bank Europe SE on behalf of the Dollar Underwriters. Payment for (i)&nbsp;the Euro Securities shall be effected either by
wire transfer of immediately available funds to a bank account, the account details for which are to be provided by the Euro Notes Issuer or the Guarantor to the Euro Representatives at least two business days in advance of the Delivery Date, or by
such other manner of payment as may be agreed by the Euro Notes Issuer or the Guarantor and the Euro Representatives, and (ii)&nbsp;the Dollar Securities shall be effected either by wire transfer of immediately available funds to an account with a
bank in The City of New York, the account number and the ABA number for such bank to be provided by the Dollar Notes Issuer or the Guarantor to the Dollar Representatives at least two business days in advance of the Delivery Date, or by such other
manner of payment as may be agreed by the Dollar Notes Issuer or the Guarantor and the Dollar Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Euro Notes Issuer will deliver against payment of the euro purchase price the Euro Securities in the
form of one or more permanent global certificates (the &#147;<B><U>Euro Global Securities</U></B>&#148;). The Euro Global Securities will be deposited on the Delivery Date with, and registered in the name of a common depositary for, Euroclear Bank
SA/NV (&#147;<B><U>Euroclear</U></B>&#148;) and for Clearstream Banking S.A. (&#147;<B><U>Clearstream</U></B>&#148;). Beneficial interests in the Euro Securities will be shown on, and transfers thereof will be effected only through, records
maintained in book-entry form by Euroclear or Clearstream, as applicable. The Euro Global Securities will be made available, at the request of the Euro Representatives, for checking at least 24 hours prior to the Delivery Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The Dollar Notes Issuer will deliver against payment of the dollar purchase price the Dollar Securities in
the form of one or more permanent global certificates (the &#147;<B><U>Dollar Global Securities</U></B>&#148;), registered in the name of Cede&nbsp;&amp; Co., as nominee for The Depository Trust Company (&#147;<B><U>DTC</U></B>&#148;). Beneficial
interests in the Dollar Securities will be shown on, and transfers thereof will be effected only through, records maintained in book-entry form by DTC and its participants, Euroclear or Clearstream, as applicable.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
The Dollar Global Securities will be made available, at the request of the Dollar Representatives, for checking at least 24 hours prior to the Delivery Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a
further condition of the obligations of the Underwriters hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) Solely for the purposes of the
requirements of Article 9(8) of the MIFID Product Governance rules under EU Delegated Directive 2017/593 (the &#147;<B><U>Product Governance Rules</U></B>&#148;) regarding the mutual responsibilities of manufacturers under the Product Governance
Rules: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) with respect to the Euro Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A. Citigroup Global Markets Europe AG, Goldman Sachs Bank Europe SE, Mizuho Securities Europe GMBH and MUFG
Securities (Europe) N.V. (each a &#147;<B><U>Euro EU Manufacturer</U></B>&#148; and together the &#147;<B><U>Euro EU Manufacturers</U></B>&#148;) acknowledges to each other Euro EU Manufacturer that it understands the responsibilities conferred upon
it under the Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Euro Securities and the related information set out in the Preliminary Prospectus,
the Prospectus. the Registration Statement and any other announcements in connection with the Euro Securities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B. the Euro Notes Issuer and the Guarantor and the Euro Underwriters (other than Euro EU Manufacturers) note
the application of the Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Euro Securities by the Euro EU Manufacturers and the related information set out in the Preliminary Prospectus,
the Prospectus, the Registration Statement and any other announcements in connection with the Euro Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) With respect to the Euro Notes, Citigroup Global Markets Europe AG, or such other Euro Underwriter as the
Euro Underwriters may agree, in its capacity as settlement bank (the &#147;<U>Settlement Bank</U>&#148;), on behalf of the Euro Underwriters, shall coordinate with the Euro Notes Issuer to ensure settlement of the Euro Notes after the Execution
Time. The Settlement Bank acknowledges that the Euro Notes represented by the Euro Global Securities will initially be credited free of payment to an account (the &#147;<U>Commissionaire Account</U>&#148;) for the benefit of the Settlement Bank, the
terms of which include a third-party beneficiary clause (&#145;<I>stipulation pour autrui</I>&#146;), with the Euro Notes Issuer as the third-party beneficiaries, and which provide that such Euro Notes are to be delivered to investors only against
payment of the net proceeds of the offering of the Euro Notes into the Commissionaire Account by the Settlement Bank on a delivery against payment basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) The Settlement Bank acknowledges that (i)&nbsp;the Euro
Notes represented by the Euro Global Securities shall be held to the order of the Euro Notes Issuer as set out in clause (f)&nbsp;above and (ii)&nbsp;the net proceeds of the offering of the Euro Notes received in the Commissionaire Account from the
Settlement Bank will be held on behalf of the Euro Notes Issuer until such time as they are transferred to the Euro Notes Issuer&#146;s order. The Settlement Bank undertakes that the net proceeds of the offering in the Commissionaire Account will be
transferred to the Euro Notes Issuer&#146;s order immediately following receipt of such net proceeds in the Commissionaire Account (and for the avoidance of doubt, no later than the Closing Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) The Euro Notes Issuer acknowledges and accepts the benefit of the third-party beneficiary clause
(&#145;<I>stipulation pour autrui</I>&#146;) pursuant to the Belgian Civil Code, in the case of Euroclear, and the Luxembourg Civil Code, in the case of Clearstream, in each case in respect of the Commissionaire Account. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Further Agreements of the Issuers and the Guarantor.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Issuers (except for the agreements in Section&nbsp;3(a) and Section&nbsp;3(p), which are given by the Euro Notes
Issuer only) and the Guarantor, jointly and severally, further agree: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) (i) To use reasonable efforts to
have the Euro Notes admitted to the Official List of Euronext Dublin and admitted to trading on the Global Exchange Market as soon as reasonably practicable; and (ii)&nbsp;to use reasonable efforts to maintain such listing for as long as any of the
Euro Notes are outstanding. If the Euro Notes cease to be listed on the Global Exchange Market of the Euronext Dublin, the Euro Notes Issuer and the Guarantor shall use reasonable efforts to relist the Euro Notes on the Euronext Dublin or to list
the Euro Notes on such other recognized stock exchange promptly and in any event before the date of the next interest payment on the Euro Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) To prepare the Prospectus in a form approved by the Representatives, which approval shall not be
unreasonably withheld or delayed, and to file such Prospectus pursuant to Rule 424(b) of the Rules and Regulations not later than Commission&#146;s close of business on the second Business Day following the execution and delivery of this Agreement;
(ii)&nbsp;to make no further amendment or any supplement to the Registration Statement or to the Prospectus (including to any Preliminary Prospectus) prior to the Delivery Date except as permitted or required herein; (iii)&nbsp;to advise the
Representatives, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or any supplement to the Prospectus or any amended Prospectus has been filed and to furnish the Underwriters with
copies thereof; (iv)&nbsp;to file promptly all reports required to be filed by the Issuer with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the
delivery of a prospectus is required </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
in connection with the offering or sale of the Securities; (v)&nbsp;to advise the Representatives, promptly after it receives notice thereof, of the issuance by the Commission of any stop order
or of any order preventing or suspending or objecting to the use of the Prospectus, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such
purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information; and (vi)&nbsp;in the event of the issuance of any stop order or of any order preventing or
suspending or objecting to the use of the Prospectus or suspending any such qualification, to use promptly its reasonable best efforts to obtain its withdrawal, including, if necessary, by filing an amendment to the Registration Statement or a new
registration statement and using its best efforts to have such amendment or new registration statement declared effective as soon as practicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) To prepare a final term sheet, containing solely a description of the Securities and the offering thereof,
in a form approved by the Representatives and to file such term sheet pursuant to Rule 433(d) of the Rules and Regulations within the time required by such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) (i) Each of the Issuers and the Guarantor agrees that, unless it obtains or will obtain the prior written
consent of the Representatives, and (ii)&nbsp;each Underwriter, severally and not jointly, agrees with the Issuers and the Guarantor that, unless it has obtained or will obtain, as the case may be, the prior written consent of the Guarantor, it has
not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in Rule 405 of the Rules and Regulations)
required to be filed by the Issuers or the Guarantor with the Commission or retained by the Issuers or the Guarantor under Rule 433 of the Rules and Regulations, other than the final term sheet prepared and filed pursuant to Section&nbsp;3(c)
hereto; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule II hereto and any electronic road show. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any such free writing prospectus consented to by the Representatives or the Issuers and the Guarantor is hereinafter referred
to as a &#147;Permitted Free Writing Prospectus.&#148; The Issuers and the Guarantor agree that (x)&nbsp;they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and
(y)&nbsp;they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Rules and Regulations applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission,
legending and record keeping. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) To furnish promptly to the Underwriters and to counsel for the
Underwriters, Baker McKenzie LLP, if requested a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
signed or facsimile signed copy of the Registration Statement as originally filed with the Commission, and each amendment thereto filed with the Commission, including all consents and exhibits
filed therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) If, at any time prior to the filing of the Prospectus pursuant to Rule 424(b) of the
Rules and Regulations, any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances
under which they were made at such time not misleading, the Issuers will (i)&nbsp;notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii)&nbsp;amend or supplement the
Disclosure Package to correct such statement or omission; and (iii)&nbsp;supply any amendment or supplement to the Underwriters in such quantities as the Underwriters may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) To deliver promptly to the Underwriters and counsel for the Underwriters such number of the following
documents as the Underwriters shall reasonably request: (i)&nbsp;conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding exhibits) and (ii)&nbsp;the Prospectus and any
amended or supplemented Prospectus and any Preliminary Prospectus, and each Issuer Free Writing Prospectus, and, if the delivery of a prospectus is required at any time after the Execution Time in connection with the offering or sale of the
Securities (including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations) and if at such time any events shall have occurred as a result of which the Prospectus as then amended or supplemented
would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading when such Prospectus is
delivered, or, if, in the opinion of counsel for the Underwriters, for any other reason it shall be necessary to amend or supplement the Prospectus in order to comply with the Securities Act, to notify the Representatives and, upon their request, to
prepare and furnish without charge to the Underwriters and to any dealer in securities as many copies of an amended or supplemented Prospectus which will correct such statement or omission or effect such compliance as the Underwriters may from time
to time reasonably request. The Issuers will pay the expenses of printing and distributing to the Underwriters all such documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) During the time that delivery of a prospectus is required for the initial offering and sale of Securities
(including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations), to file promptly with the Commission any amendment to the Registration Statement or the Prospectus or any supplement to the
Prospectus, or new registration statement, that may, in the reasonable judgment of the Issuers or the Representatives, be required by the Securities Act or that is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
requested by the Commission. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) For so long as the
delivery of a prospectus is required in connection with the initial offering or sale of the Securities (including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations), prior to filing with the
Commission any amendment to the Registration Statement, supplement to the Prospectus, Prospectus (including any Preliminary Prospectus), any document incorporated by reference in the Prospectus or any new registration statement, to furnish a copy
thereof to the Underwriters and counsel for the Underwriters and obtain the consent of the Representatives, which consent shall not unreasonably be withheld or delayed. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) To apply the proceeds from the sale of the Securities as set forth under &#147;Use of Proceeds&#148; in
each of the Preliminary Prospectus and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(k) From the date hereof through the Closing Date,
not to, directly or indirectly, offer for sale, sell or otherwise dispose of (or enter into any transaction or device which is designed to, or could be expected to, result in the disposition or purchase by any person at any time in the future of),
or announce an offering of any debt securities issued or guaranteed by the Guarantor or either of the Issuers without the prior written consent of the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(l) Not to take, directly or indirectly, any action designed to cause or result in, or which has constituted or
which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Guarantor or either of the Issuers in connection with the offering of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(m) Cooperate with the Representatives, if necessary, for the qualification of the Securities for sale by the
Underwriters under the laws of such jurisdictions as the Representatives may designate (including Japan and certain provinces of Canada) and maintain such qualifications in effect so long as required for the sale of the Securities; provided that in
no event shall the Issuers be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale
of the Securities, in any jurisdiction where it is not now so subject or to subject itself to taxation in any jurisdiction wherein it would not otherwise be subject to tax but for the requirements of this paragraph. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(n) To take such steps as shall be necessary to ensure that neither of the Issuers nor the Guarantor shall
become an &#147;investment company&#148; within the meaning of such term under the Investment Company Act and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(o) To make reasonable commercial efforts so that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
neither of the Issuers will be deemed an Israeli tax resident. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(p) To use its reasonable best efforts to cause the Securities to be accepted for clearance and settlement
through the facilities of DTC, Euroclear or Clearstream, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(q) To hereby confirm the
appointment of Citigroup Global Markets Europe AG in its role as stabilizing manager (the &#147;<B><U>Euro Stabilizing Manager</U></B>&#148;) as the central point responsible for adequate public disclosure of information, and handling any request
from a competent authority, in accordance with Article 6(5) of Commission Delegated Regulation (EU) 2016/1052 of 8&nbsp;March 2016 supplementing Regulation (EU) No.&nbsp;596/2014 of the European Parliament and of the Council with regard to
regulatory technical standards for the conditions applicable to buyback programs and stabilization measures. The Euro Stabilizing Manager for its own account may, to the extent permitted by applicable laws and directives, over-allot and effect
transactions with a view to supporting the market price of the Euro Securities at a level higher than that which might otherwise prevail, but in doing so the Euro Stabilizing Manager shall act as principal and not as agent of the Euro Notes Issuer
or the Guarantor and any loss resulting from overallotment and stabilization shall be borne, and any profit arising therefrom shall be beneficially retained, by the Euro Stabilizing Manager. However, there is no assurance that the Euro Stabilizing
Manager (or persons acting on behalf of the Euro Stabilizing Manager) will undertake any stabilization action. Nothing contained in this paragraph shall be construed so as to require the Euro Notes Issuer to issue, or the Guarantor to guarantee, in
excess of (i) &#128;800,000,000 in aggregate principal amount of the 2029 Euro Notes or (ii) &#128;500,000,000 in aggregate principal amount of the 2031 Euro Notes. Such stabilization, if commenced, may be discontinued at any time and shall be
conducted by the Euro Stabilizing Manager in accordance with all applicable laws and directives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(r) To
hereby confirm the appointment of Goldman Sachs Bank Europe SE in its role as stabilizing manager (the &#147;<B><U>Dollar Stabilizing Manager</U></B>&#148;) as the central point responsible for adequate public disclosure of information, and handling
any request from a competent authority, in accordance with Article 6(5) of Commission Delegated Regulation (EU) 2016/1052 of 8&nbsp;March 2016 supplementing Regulation (EU) No.&nbsp;596/2014 of the European Parliament and of the Council with regard
to regulatory technical standards for the conditions applicable to buyback programs and stabilization measures. The Dollar Stabilizing Manager for its own account may, to the extent permitted by applicable laws and directives, over-allot and effect
transactions with a view to supporting the market price of the Dollar Securities at a level higher than that which might otherwise prevail, but in doing so the Dollar Stabilizing Manager shall act as principal and not as agent of the Dollar Notes
Issuer or the Guarantor and any loss resulting from overallotment and stabilization shall be borne, and any profit arising therefrom shall be beneficially retained, by the Dollar Stabilizing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Manager. However, there is no assurance that the Dollar Stabilizing Manager (or persons acting on behalf of the Dollar Stabilizing Manager) will undertake any stabilization action. Nothing
contained in this paragraph shall be construed so as to require the Dollar Notes Issuer to issue, or the Guarantor to guarantee, in excess of (i) $600,000,000 in aggregate principal amount of the 2029 Dollar Notes or (ii) $500,000,000 in aggregate
principal amount of the 2031 Dollar Notes. Such stabilization, if commenced, may be discontinued at any time and shall be conducted by the Dollar Stabilizing Manager in accordance with all applicable laws and directives. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Expenses.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Issuers (except for the expenses in Section&nbsp;4(f), which are applicable only to the Euro Notes Issuer) and the
Guarantor, jointly and severally, agree to pay: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) the costs incident to the authorization, issuance,
sale and delivery of the Securities, and any taxes payable in that connection; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) the costs incident to
the preparation, printing and distribution of the Prospectus and any amendment or supplement to the Prospectus (including any Preliminary Prospectus) or the Registration Statement and any Issuer Free Writing Prospectus, all as provided in this
Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) the costs of producing and distributing the Operative Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) the fees and expenses of Kirkland&nbsp;&amp; Ellis LLP (&#147;<B><U>Kirkland</U></B>&#148;), Agmon with
Tulchinsky Law Firm (&#147;<B><U>Tulchinsky</U></B>&#148;), Van Doorne N.V. (&#147;<B><U>Van </U></B><B><U>Doorne</U></B>&#148;) and Kesselman&nbsp;&amp; Kesselman; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) the costs of distributing the terms of agreement relating to the organization of the underwriting syndicate
and selling group to the members thereof by mail or other means of communication and any transfer and stamp tax on the Securities due upon resale by the Underwriters of Securities purchased under this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) all fees incurred in connection with the listing of the Euro Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) all travel costs for personnel of the Issuers and the Guarantor (but excluding travel expenses of the
Underwriters relating to the road show) and the costs associated with any chartered plane used in connection with the road show; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) all fees and expenses incurred in connection with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
any rating of the Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the costs of
preparing the Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) the fees and expenses (including fees and disbursements of counsel) of the
Trustee, and the costs and charges of any registrar, transfer agent, paying agent or calculation agent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(k) all fees and expenses incurred in connection with sustainability-linked structuring of the Securities,
including but not limited to the sustainability-linked financial framework and second party opinions; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(l) all other costs and expenses incidental to the performance of the obligations of the Issuers and the
Guarantor under this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>provided</U>, <U>however</U>, that, except as provided in Sections 4, 7
and 10, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, which costs and expenses shall be divided <I>pro rata </I>among the Underwriters in the proportions that the total aggregate
principal amount of Securities set opposite the name of each Underwriter in Schedule I bears to the total aggregate principal amount of Securities. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Conditions of the Underwriters&#146; Obligations.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The several obligations of the Underwriters hereunder are subject to the accuracy, at the Execution Time and on the Delivery
Date, of the representations and warranties of each of the Issuers and the Guarantor contained herein, to the performance by each of the Issuers and the Guarantor of its obligations hereunder, and to each of the following additional terms and
conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) No Underwriter shall have discovered and disclosed to the Issuers or the Guarantor prior
to or on the Delivery Date that the Disclosure Package, the Prospectus or any amendment or supplement thereto contains any untrue statement of a fact which, in the opinion of counsel to the Underwriters, is material or omits to state any fact which
is material and necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or that the Registration Statement or any amendment thereto contains any untrue statement of a fact
which, in the opinion of counsel to the Underwriters, is material or omits to state any fact which is material and necessary to make the statements therein not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) The Prospectus shall have been timely filed with the Commission in accordance with Section&nbsp;3(a) of
this Agreement; the final term sheet contemplated by Section&nbsp;3(c) hereof, and any other material required to be filed by the Guarantor pursuant to Rule 433(d) of the Rules and Regulations shall have been filed with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Commission within the applicable time periods prescribed for such filings by Rule 433 of the Rules and Regulations; no stop order suspending the effectiveness of the Registration Statement or
any part thereof or any notice that objects to or would prevent its use shall have been issued and no proceeding for that purpose shall have been initiated or, to the knowledge of any of the parties hereto, threatened by the Commission; and any
request of the Commission for inclusion of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) All corporate proceedings and other legal matters incident to the authorization, form and validity of the
Operative Documents and the Prospectus or any amendment or supplement thereto, and all other legal matters relating to the Operative Documents and the transactions contemplated thereby shall be satisfactory in all material respects to counsel to the
Underwriters, and the Issuers and the Guarantor shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Kirkland shall have furnished to the Underwriters their written opinion and negative assurance letter, as
U.S. counsel to the Issuers and the Guarantor, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit A hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) Van Doorne shall have furnished to the Underwriters their written opinion, as Netherlands counsel to the
Issuers and the Guarantor, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit B hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) Tulchinsky shall have furnished to the Underwriters their written opinion, as Israeli counsel to the
Guarantor, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit C hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) David M. Stark, Executive Vice President and Chief Legal Officer of the Guarantor, shall have furnished to
the Underwriters his written opinion addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives, to the effect set forth in Exhibit D hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) Baker&nbsp;&amp; McKenzie LLP shall have furnished to the Underwriters their written opinion and negative
assurance letter, as U.S. counsel to the Underwriters, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) Herzog, Fox&nbsp;&amp; Neeman shall have furnished to
the Underwriters their written opinion, as Israeli counsel to the Underwriters, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) Kesselman&nbsp;&amp; Kesselman, independent auditors for the Guarantor, shall have delivered to the
Underwriters a customary &#147;comfort letter&#148; in form and substance satisfactory to the Underwriters and dated as of the Execution Time (the &#147;<B><U>K&amp;K initial letter</U></B>&#148;), and a letter addressed to the Underwriters and
dated as of the Delivery Date (the &#147;<B><U>K&amp;K bring-down letter</U></B>&#148;), (i) confirming that they are the independent registered accounting firm with respect to the Guarantor within the meaning of the Securities Act and the Rules and
Regulations, (ii)&nbsp;stating, as of the date of the K&amp;K bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the Prospectus or the
Disclosure Package, as of a date not more than five days prior to the date of the K&amp;K bring-down letter), the conclusions and findings of such firm with respect to the financial information and other matters covered by the K&amp;K initial letter
and (iii)&nbsp;confirming in all material respects the conclusions and findings set forth in the K&amp;K initial letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(k) Each of the Issuers shall have furnished to the Representatives on the Delivery Date a certificate, dated
such Delivery Date and delivered on behalf of each of the Issuers by one of its managing or supervisory directors or a duly authorized <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> in form and
substance satisfactory to the Underwriters, to the effect that the representations and warranties of such Issuer in Section&nbsp;1 are true and correct as of the date given and as of such Delivery Date and such Issuer has complied in all material
respects with all its agreements contained herein to be performed prior to or on such Delivery Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(l)
The Guarantor shall have furnished to the Representatives on the Delivery Date a certificate, dated such Delivery Date and delivered on behalf of the Guarantor by its chief executive officer, chief operating officer, chief financial officer or
senior vice president, corporate treasurer, in form and substance satisfactory to the Underwriters, to the effect that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) The representations and warranties of the Guarantor in Section&nbsp;1 are true and correct as of the date
given and as of such Delivery Date; and the Guarantor has complied in all material respects with all its agreements contained herein to be performed prior to or on such Delivery Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) (A) Except as would not have a Material Adverse Effect, the Guarantor has not sustained since the date of
the latest audited financial statements incorporated by reference in the Prospectus any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or
decree, except (x)&nbsp;as set forth or contemplated in the Prospectus or the Disclosure Package (exclusive of any amendments or supplements thereto) and (y)&nbsp;for operating losses incurred in the ordinary course of business, and (B)&nbsp;since
such date there has not been any change in the capital stock or long-term debt of the Guarantor (except for issuances of shares of Ordinary Shares upon exercise of outstanding options described in the Disclosure Package or pursuant to Authorized
Grants), except as set forth or contemplated in the Prospectus or the Disclosure Package (exclusive of any amendments or supplements thereto), or any change, or any development involving a prospective change, that would have a Material Adverse
Effect; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) Such officer has carefully examined the Prospectus and the Disclosure Package, in such
officer&#146;s opinion (A)&nbsp;each of the Prospectus and the Disclosure Package, as of its date and the Execution Time, respectively, did not include any untrue statement of a material fact and did not omit to state any material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading, and (B)&nbsp;since the date of the Prospectus, no event has occurred which should have been set forth in a supplement or amendment to the
Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(m) Each of the Supplemental Indentures shall have been duly executed and delivered by each of
the Issuer party thereto, the Guarantor, the Trustee and any paying agent (if applicable); and the Notes and the Guarantees shall have been duly executed and delivered by each of the Issuer party thereto and the Guarantor, respectively, and duly
authenticated by the Trustee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(n) Since the date of the latest audited financial statements incorporated
by reference in the Disclosure Package (exclusive of any amendment or supplement thereto), there shall not have been (i)&nbsp;any material adverse change in the Guarantor&#146;s capital stock or long-term debt, or (ii)&nbsp;any material adverse
change or development involving a prospective material adverse change, in or affecting the condition (financial or otherwise), stockholders&#146; equity or results of operations of the Guarantor and its subsidiaries, taken as a whole, except as set
forth or contemplated in each of the most recent Preliminary Prospectus and the Prospectus(exclusive of any amendment or supplement thereto), the effect of which, in any such case described in clause (i)&nbsp;or (ii), is, in the reasonable judgment
of the Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or the delivery of the Securities being delivered on the Delivery Date on the terms and in the manner contemplated in the Disclosure
Package and the Prospectus (exclusive of any amendment or supplement thereto) and any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(o) Each of the Issuers and the Guarantor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
shall have furnished to the Representatives such further information, certificates and documents as the Representatives may reasonably request to evidence compliance with the conditions set forth
in this Section&nbsp;5. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(p) All opinions, letters, evidence and certificates mentioned above or elsewhere
in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel to the Underwriters. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Representations, Warranties and Agreements of Underwriters.</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each Underwriter, severally and not jointly, represents, warrants to and agrees with each of the
Issuers and the Guarantor that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) It has only communicated or caused to be communicated and will only
communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (the &#147;<B><U>FSMA</U></B>&#148;)) received by it in
connection with the issue or sale of the Securities in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to the Issuers or the Guarantor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) It has complied and will comply with all applicable provisions of the FSMA with respect to anything done by
it in relation to the Securities in, from or otherwise involving the United Kingdom. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) It has not
offered, sold or otherwise made available and will not offer, sell or otherwise make available any Securities to any retail investor in the United Kingdom. For the purposes of this provision the expression &#147;retail investor&#148; means a person
who is one (or more) of the following: (A)&nbsp;a retail client, as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the EUWA; or (B)&nbsp;a customer within the meaning of the
provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014
as it forms part of domestic law by virtue of the EUWA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) It has not offered, sold or otherwise made
available and will not offer, sell or otherwise make available any Securities to any retail investor in the European Economic Area. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) For the purposes of this provision the expression &#147;retail investor&#148; means a person who is one (or
more) of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. a retail client as defined in point
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended, &#147;<B><U>MiFID II</U></B>&#148;); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify
as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. not a qualified
investor as defined in Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) For the purposes of this provision the expression
&#147;offer&#148; includes the communication in any form and by any means of sufficient information on the terms of the offer and the Securities to be offered so as to enable an investor to decide to purchase or subscribe for the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) Any offers in Canada will be made only under an exemption from the requirements to file a prospectus in the
relevant province of Canada in which the sale is made. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) Any offers in the Netherlands will be made only
to qualified investors as defined in Regulation (EU) 2017/1129, as amended and as implemented from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) It will (i)&nbsp;purchase, accept delivery of and make payment for the Securities outside the State of
Israel and (ii)&nbsp;not offer or sell the Securities in the State of Israel, other than offers or sales to persons (A)&nbsp;who qualify as one of the types of investors listed in the First Addendum to the Israeli Securities Law, subject to and in
accordance with the requirements set forth in the First Addendum to the Israeli Securities Law, and (B)&nbsp;who have confirmed in writing that they are purchasing the Securities for their own account and not with a view to, or for resale in
connection with, any distribution thereof; except, to the extent permitted under the First Addendum to the Israeli Securities Law, for resale to qualified investors of the types listed therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) It will comply with applicable laws and regulations in each jurisdiction in which it acquires, offers,
sells or delivers Securities, or has in its possession or distributes any Free Writing Prospectus, the Disclosure Package, the Preliminary Prospectus and the Prospectus. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Indemnification and Contribution.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Each of the Issuers and the Guarantor, jointly and severally, shall indemnify and hold harmless each
Underwriter, its officers, employees, agents, affiliates and each person, if any, who controls any Underwriter within the meaning of the Securities Act, from and against any loss, claim, damage or liability, joint or several, or any action in
respect thereof (including, but not limited to, any loss, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
claim, damage, liability or action relating to purchases and sales of the Securities), to which that Underwriter, officer, employee, agent, affiliate or controlling person may become subject,
insofar as such loss, claim, damage, liability or action arises out of, or is based upon: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) any untrue
statement or alleged untrue statement of a material fact contained in the Prospectus, the Preliminary Prospectus, the Registration Statement, any Issuer Free Writing Prospectus, any materials used by the Issuers or the Guarantor in meetings with
investors (including any electronic road show), or the information contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any amendment or supplement thereto; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the omission or alleged omission to state therein any material fact necessary to make the statements
therein not misleading, and shall reimburse each Underwriter and each such officer, employee, agent, affiliate and controlling person promptly upon demand for any legal or other expenses reasonably incurred by that Underwriter, officer, employee,
agent, affiliate or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; <U>provided</U>, <U>however</U>, that neither of the
Issuers nor the Guarantor shall be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in
the Preliminary Prospectus, the Prospectus, the Registration Statement, any Issuer Free Writing Prospectus, any materials used by the Issuers or the Guarantor in meetings with investors (including any electronic road show), or the information
contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any such amendment or supplement thereto, in reliance upon and in conformity with the written information furnished to the Issuers or the
Guarantor by or on behalf of any Underwriter specifically for inclusion therein and described in Section&nbsp;7(e). The foregoing indemnity agreement is in addition to any liability that the Issuers or the Guarantor may otherwise have to any
Underwriter or to any officer, employee, agent, affiliate or controlling person of that Underwriter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b)
Each Underwriter, severally and not jointly, shall indemnify and hold harmless, each of the Issuers and the Guarantor, its officers and directors, agents, employees and each person, if any, who controls each of the Issuers or the Guarantor within
the meaning of the Securities Act from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the Issuers or the Guarantor or their respective directors, officers, agents, employees or
controlling persons may become subject, insofar as such loss, claim, damage, liability or action arises out of, or is based upon: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus, the
Preliminary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Prospectus, any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereto, or in any amendment or
supplement thereto; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the omission or alleged omission to state therein any material fact necessary
to make the statements therein not misleading, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">but in each case only to the extent that such untrue
statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with the written information furnished to the Issuers or the Guarantor by or on behalf of that Underwriter specifically for inclusion
therein and described in Section&nbsp;7(e), and shall reimburse the Issuers and the Guarantor and any such director, officer, agent, employee or controlling person promptly upon demand for any legal or other expenses reasonably incurred by the
Issuers or the Guarantor or any such director, officer, agent, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are
incurred. The foregoing indemnity agreement is in addition to any liability which any Underwriter may otherwise have to the Issuers, the Guarantor or any such director, officer, agent, employee or controlling person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Promptly after receipt by an indemnified party under this Section&nbsp;7 of notice of any claim or the
commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;7, notify the indemnifying party in writing of the claim or the commencement of that action;
provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section&nbsp;7 except to the extent it has been materially prejudiced by such failure; and, provided, further,
that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section&nbsp;7. If any such claim or action shall be brought against an indemnified party,
and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with
counsel satisfactory to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under
this Section&nbsp;7 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that the Underwriters shall have the right to
employ counsel to represent jointly the Underwriters and their respective officers, employees, agents, affiliates and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the
Underwriters against the Issuers under this Section&nbsp;7, if the Underwriters shall have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
reasonably concluded that there may be one or more legal defenses available to the Underwriters and their respective officers, employees, agents, affiliates and controlling persons that are
different from or additional to those available to the Issuers and the Guarantor and their respective officers, directors, employees, agents, affiliates and controlling persons, and the reasonable fees and expenses of a single separate counsel shall
be paid, jointly and severally, by each of the Issuers and the Guarantor. No indemnifying party shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i)
without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld) settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding
in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent (A)&nbsp;includes an
unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and (B)&nbsp;does not include any statement as to or an admission of fault, culpability or a failure to act, by or on behalf of
any indemnified party, or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) be liable for any settlement of any such action effected without its
written consent (which consent shall not be unreasonably withheld), but if settled with its written consent or if there be a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any
indemnified party from and against any loss or liability by reason of such settlement or judgment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) If
the indemnification provided for in this Section&nbsp;7 shall for any reason be unavailable or insufficient to hold harmless an indemnified party under Section&nbsp;7(a) or 7(b) in respect of any loss, claim, damage or liability, or any action in
respect thereof, referred to therein, each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action
in respect thereof: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) in such proportion as shall be appropriate to reflect the relative benefits
received by the Issuers and the Guarantor on the one hand and the Underwriters on the other from the offering of the Securities, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) if the allocation provided by clause 7(d)(i) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause 7(d)(i) but also the relative fault of the Issuers and the Guarantor on the one hand and the Underwriters on the other with respect to the statements or omissions or alleged
statements or alleged omissions that resulted in such loss, claim, damage or liability (or action in respect thereof), as well as any other relevant equitable considerations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The relative benefits received by the Issuers and the
Guarantor on the one hand and the Underwriters on the other with respect to such offering shall be deemed to be in the same proportion as the total net proceeds from the offering of the Securities purchased under this Agreement (before deducting
expenses) received by the Issuers on the one hand, and the total discounts and commissions received by the Underwriters with respect to the Securities purchased under this Agreement, on the other hand, bear to the total gross proceeds from the
offering of the Securities under this Agreement, in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or
omission or alleged omission to state a material fact relates to information supplied by the Issuers or the Guarantor on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Issuers, the Guarantor and the Underwriters agree that it would not be just and equitable if the amount of contributions pursuant to this Section&nbsp;7(d) were to be determined by
<U>pro rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take into account the equitable considerations referred to herein. The amount paid or payable by an
indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section&nbsp;7(d) shall be deemed to include, for purposes of this Section&nbsp;7(d), any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;7(d), no Underwriter shall be required to contribute any amount in excess of
the amount by which the total price at which the Securities resold by it in the initial placement of such Securities were offered to investors exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute as provided in this Section&nbsp;7(d) are several in proportion to their respective purchase obligations and not joint. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) The Underwriters severally confirm that the statements with respect to the delivery of the Securities set
forth on the cover page of the Prospectus and the Preliminary Prospectus and the first paragraph under the <FONT STYLE="white-space:nowrap">sub-caption</FONT> &#147;Price Stabilization and Short Positions&#148; and the allocation table under the
caption &#147;Underwriting&#148; in the Prospectus and the most recent Preliminary Prospectus are correct and constitute the only information furnished in writing to the Issuers and the Guarantor by or on behalf of the Underwriters specifically for
inclusion in the most recent Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or the information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
contained in the final term sheet required to be prepared and filed pursuant to Section&nbsp;3(c) hereof. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Defaulting Underwriters. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If, on the Delivery Date, any Euro Underwriter defaults in the performance of its obligations under this
Agreement, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters shall be obligated to purchase the aggregate principal amount of such series of Euro Securities which the defaulting Euro Underwriter agreed but failed
to purchase on such Delivery Date in the respective proportions which the total aggregate principal amount of such series of Euro Securities set opposite the name of each remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro
Underwriter in Part A of Schedule I hereto bears to the total aggregate principal amount of such series of Euro Securities set opposite the names of all the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters in Part A
of <B>Schedule I</B> hereto; <U>provided</U>, <U>however</U>, that the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters shall not be obligated to purchase any such series of Euro Securities on such Delivery Date if
the total aggregate principal amount of such series of Euro Securities which the defaulting Euro Underwriters agreed but failed to purchase on such date exceeds 10.0% of the total aggregate principal amount of such series of Euro Securities to be
purchased on such Delivery Date, and any remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriter shall not be obligated to purchase more than 110.0% of the aggregate principal amount of any series of Euro Securities which
it agreed to purchase on such Delivery Date pursuant to the terms of Section&nbsp;2. If the foregoing maximums are exceeded, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro Underwriters, or those other purchasers
satisfactory to the Euro Underwriters who so agree, shall have the right, but shall not be obligated, to purchase on such Delivery Date, in such proportion as may be agreed upon among them, the total aggregate principal amount of any series of Euro
Securities to be purchased on such Delivery Date. If the remaining Euro Underwriters or other purchasers satisfactory to the Euro Underwriters do not elect to purchase on such Delivery Date the aggregate principal amount of the series of Euro
Securities which the defaulting Euro Underwriters agreed but failed to purchase, this Agreement shall terminate with respect to the Euro Underwriters without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Euro
Underwriters and the Issuers and the Guarantor, except that the Issuers and the Guarantor will continue to be liable for the payment of expenses to the extent set forth in Sections 4 and 10. As used in this Agreement, the term &#147;<U>Euro</U>
<U>Underwriter</U>&#148; includes, for all purposes of this Agreement unless the context requires otherwise, any party not listed in Part A of <B>Schedule I</B> hereto who, pursuant to this Section&nbsp;8, purchases any series of Euro Securities
which a defaulting Euro Underwriter agreed but failed to purchase. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If, on the Delivery Date, any Dollar
Underwriter defaults in the performance of its obligations under this Agreement, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters shall be obligated to purchase the aggregate principal amount of such series of
Dollar Securities which the defaulting Dollar Underwriter agreed but failed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to purchase on such Delivery Date in the respective proportions which the total aggregate principal amount of such series of Dollar Securities set opposite the name of each remaining <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriter in Part B of Schedule I hereto bears to the total aggregate principal amount of such series of Dollar Securities set opposite the names of all the remaining <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters in Part B of SCHEDULE I hereto; <U>provided</U>, <U>however</U>, that the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters shall not be
obligated to purchase any such series of Dollar Securities on such Delivery Date if the total aggregate principal amount of such series of Dollar Securities which the defaulting Dollar Underwriters agreed but failed to purchase on such date exceeds
10.0% of the total aggregate principal amount of such series of Dollar Securities to be purchased on such Delivery Date, and any remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriter shall not be obligated to purchase
more than 110.0% of the aggregate principal amount of any series of Dollar Securities which it agreed to purchase on such Delivery Date pursuant to the terms of Section&nbsp;2. If the foregoing maximums are exceeded, the remaining <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters, or those other purchasers satisfactory to the Dollar Underwriters who so agree, shall have the right, but shall not be obligated, to purchase on such Delivery Date, in such
proportion as may be agreed upon among them, the total aggregate principal amount of any series of Dollar Securities to be purchased on such Delivery Date. If the remaining Dollar Underwriters or other purchasers satisfactory to the Dollar
Underwriters do not elect to purchase on such Delivery Date the aggregate principal amount of the series of Dollar Securities which the defaulting Dollar Underwriters agreed but failed to purchase, this Agreement shall terminate with respect to the
Dollar Underwriters without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Dollar Underwriters and the Issuers and the Guarantor, except that the Issuers and the Guarantor will continue to be liable for the
payment of expenses to the extent set forth in Sections 4 and 10. As used in this Agreement, the term &#147;<U>Dollar Underwriter</U>&#148; includes, for all purposes of this Agreement unless the context requires otherwise, any party not listed in
Part B of SCHEDULE I hereto who, pursuant to this Section&nbsp;8, purchases any series of Dollar Securities which a defaulting Dollar Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Issuers for
damages caused by its default. If other purchasers are obligated or agree to purchase the Securities of a defaulting or withdrawing Underwriter, either the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Issuers
may postpone the Delivery Date for up to seven full business days in order to effect any changes in the Prospectus or in any other document or arrangement that, in the opinion of counsel to the Issuers and the Guarantor or counsel to the
Underwriters, may be necessary. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Termination.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the
Issuers and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Guarantor prior to delivery of and payment for the Securities, after the execution and delivery of this Agreement and prior to the Delivery Date, any of the following events shall have
occurred (i)&nbsp;trading in securities generally on the New York Stock Exchange, or trading in any securities of the Guarantor on any exchange shall have been suspended or minimum prices shall have been established on any such exchange or market by
the Commission, by such exchange or by any other regulatory body or governmental authority having jurisdiction; (ii)&nbsp;a banking moratorium shall have been declared by United States federal or New York State authorities or a material disruption
shall have occurred in commercial banking or securities settlement or clearance services in the United States; (iii)&nbsp;there shall have occurred any outbreak or escalation in hostilities involving the United States, or there shall have been a
declaration of a national emergency or war by the United States or The Netherlands; (iv)&nbsp;the rating accorded the Guarantor&#146;s debt securities shall have been downgraded by any &#147;nationally recognized statistical rating
organization,&#148; as that term is defined in Section&nbsp;3(a)(62) of the Exchange Act, or such an organization shall have made any public announcement that it has under surveillance or review, with possible negative implications for a downgrade,
its rating of any of the Guarantor&#146;s debt securities; or (v)&nbsp;there shall have occurred such a material adverse change in general economic, political or financial conditions (or the effect of international conditions on the financial
markets in the United States, The Netherlands or Israel shall be such) as to make it, with respect to the events in clause (iii)&nbsp;or (v) in the sole judgment of the Representatives, impracticable or inadvisable to proceed with the offering or
delivery of the Securities being delivered on such Delivery Date on the terms and in the manner contemplated in the Disclosure Package and the Prospectus. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Reimbursement of Underwriters&#146; Expenses.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If (a)&nbsp;either of the Issuers and the Guarantor shall fail to tender the Securities for delivery to the Underwriters for
any reason permitted under this Agreement or (b)&nbsp;the Underwriters shall decline to purchase the Securities because of any failure or refusal on the part of either of the Issuers or the Guarantor to comply with the terms or to fulfill any of the
conditions of this Agreement or if either of the Issuers or the Guarantor shall be unable to perform its obligations under this Agreement, the relevant Issuer(s) and the Guarantor, jointly and severally, shall reimburse the Underwriters for the fees
and expenses of their counsel and for such other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses as shall have been incurred by them in connection with this Agreement and the proposed purchase
of the Securities, and upon demand the relevant Issuer(s) shall pay the full amount thereof to the Underwriters. If this Agreement is terminated pursuant to Section&nbsp;8 by reason of the default of one or more Underwriters, the relevant Issuer(s)
shall not be obligated to reimburse any defaulting Underwriter on account of those expenses. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Notices, etc. </B></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All statements, requests, notices and agreements hereunder shall be in
writing, and: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) if to the Euro Underwriters or the Euro Representatives, shall be delivered or sent by
mail to: Citigroup Global Markets Europe AG, Reuterweg 16, 60323 Frankfurt am Main, Germany, Attention: Fixed Income Syndicate Desk (Tel: +49 69 1366 8362); Goldman Sachs Bank Europe SE, Marienturm, Taunusanlage
<FONT STYLE="white-space:nowrap">9-10,</FONT> <FONT STYLE="white-space:nowrap">D-60329</FONT> Frankfurt am Main, Germany, Attention: High Yield Syndicate Desk (Tel: +49 69 7532 1000, Fax: +44 (0)207 774 2330); Mizuho Securities Europe GMBH,
Taunustor 1, 60310 Frankfurt am Main, Germany, Attention: Primary Debt (Tel: +49 69 42729 3140, email: <FONT STYLE="white-space:nowrap">PrimaryDebt@eu.mizuho-sc.com);</FONT> MUFG Securities (Europe) N.V., World Trade Center, Tower H, 11th Floor,
Zuidplein 98, 1077 XV Amsterdam, The Netherlands, Attention: Legal-Primary Markets (email: Legal-primarymarkets@int.sc.mufg.jp); PNC Capital Markets LLC, 10th Floor, 300 Fifth Avenue, Pittsburgh, Pennsylvania 15222, United States, Attention: Debt
Capital Markets, Fixed Income Transaction Execution (Fax: +1 (412) <FONT STYLE="white-space:nowrap">762-2760);</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) if to the Dollar Underwriters or the Dollar Representatives, shall be delivered or sent by mail to:
Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York 10013, United States, Attention: General Counsel (Fax: +1 (646) <FONT STYLE="white-space:nowrap">291-1469);</FONT> Goldman Sachs Bank Europe SE, Marienturm, Taunusanlage <FONT
STYLE="white-space:nowrap">9-10,</FONT> <FONT STYLE="white-space:nowrap">D-60329</FONT> Frankfurt am Main, Germany, Attention: High Yield Syndicate Desk (Tel: +49 69 7532 1000, Fax: +44 (0)207 774 2330); Mizuho Securities USA LLC, 1271 Avenue of the
Americas, New York, New York 10020, United States, Attention: Debt Capital Markets (Fax: +1 (212) <FONT STYLE="white-space:nowrap">205-7812);</FONT> MUFG Securities Americas Inc., 1221 Avenue of the Americas, New York, New York 10020-1001, United
States, Attention: Capital Markets Group (Fax: +1 (646) <FONT STYLE="white-space:nowrap">434-3455);</FONT> PNC Capital Markets LLC, 10th Floor, 300 Fifth Avenue, Pittsburgh, Pennsylvania 15222, United States, Attention: Debt Capital Markets, Fixed
Income Transaction Execution (Fax: +1 (412) <FONT STYLE="white-space:nowrap">762-2760);</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) if to
the Guarantor, shall be delivered or sent by mail or facsimile transmission to Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi&#146;a Street, Tel Aviv, 6944020, Israel, Attention: Stephen Harper (Fax: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">011-972-3-914-8678),</FONT></FONT></FONT></FONT> with copies (which shall not constitute notice) to: (i)&nbsp;Teva Pharmaceuticals USA, Inc., 400 Interpace
Parkway, Building A Parsippany, New Jersey 07054, Attention: David M. Stark (Fax: (215) <FONT STYLE="white-space:nowrap">293-6499);</FONT> and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention: Ross
Leff and Christie Mok (Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) if to the Euro Notes Issuer, shall be delivered or sent by mail or facsimile transmission to Teva
Pharmaceutical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Finance Netherlands II B.V., Piet Heinkade 107, 1019 GM, Amsterdam, Netherlands, Attention: Managing Director, with copies (which shall not constitute notice) to: (i)&nbsp;c/o Teva
Pharmaceuticals USA, Inc., 400 Interpace Parkway, #3 Parsippany, New Jersey 07054, Attention: David M. Stark (Fax: (215) <FONT STYLE="white-space:nowrap">293-6499)</FONT> and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York,
New York 10022, Attention: Ross Leff and Christie Mok (Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) if to the Dollar Notes Issuer, shall be delivered or sent by mail or facsimile transmission to Teva
Pharmaceutical Finance Netherlands III B.V., Piet Heinkade 107, 1019 GM, Amsterdam, Netherlands, Attention: Managing Director, with copies (which shall not constitute notice) to: (i)&nbsp;c/o Teva Pharmaceuticals USA, Inc., 400 Interpace Parkway, #3
Parsippany, New Jersey 07054, Attention: David M. Stark (Fax: (215) <FONT STYLE="white-space:nowrap">293-6499)</FONT> and (ii)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York 10022, Attention: Ross Leff and Christie Mok
(Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-446-4900);</FONT></FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>provided</U>,
<U>however</U>, that any notice to an Underwriter pursuant to Section&nbsp;7(c) shall be delivered or sent by mail or facsimile transmission to each such Underwriter, which address will be supplied to any other party hereto by the Representatives
upon request. Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof. The Issuers and the Guarantor shall be entitled to act and rely upon any request, consent, notice or agreement given or made on
behalf of the Underwriters by the Representatives. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Persons Entitled to Benefit of Agreement.</I></B><B></B><B><I> </I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Issuers, the
Guarantor and their respective successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that the representations, warranties, indemnities and agreements of the Issuers and the Guarantor
contained in this Agreement shall also be deemed to be for the benefit of the officers, employees, agents and affiliates of each Underwriter and the person or persons, if any, who control each Underwriter within the meaning of Section&nbsp;15 of the
Securities Act and any indemnity agreement of the Underwriters contained in Section&nbsp;7(b) of this Agreement shall be deemed to be for the benefit of directors, officers, employees, agents and affiliates of the Issuers and the Guarantor, and any
person controlling the Issuers or the Guarantor within the meaning of Section&nbsp;15 of the Securities Act. Nothing contained in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this
Section&nbsp;12, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Survival. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The respective indemnities, representations, warranties and agreements of the Issuers, the Guarantor and the Underwriters
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
contained in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Securities and shall remain in full force
and effect, regardless of any termination or cancellation of this Agreement or any investigation made by or on behalf of any of them or any person controlling any of them. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Transfers to EU Affiliates.</I></B><B></B><B><I> </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding anything to the contrary in this Agreement, each Underwriter (whether it is an original party to this Agreement
or a party to whom this Agreement has been previously transferred pursuant to this paragraph) shall be entitled to assign or transfer all of its rights or obligations under this Agreement to any affiliate registered in the European Union or which is
also carrying on <FONT STYLE="white-space:nowrap">EU-regulated</FONT> services (in each case, the &#147;<B><U>EU Affiliate</U></B>&#148;) by notice in writing, and from the date of such transfer, references to such Underwriter shall be read as
references to such EU Affiliate. Upon completion of such assignment or transfer of all rights and obligations under this Agreement, each transferor pursuant to this Section&nbsp;14 shall be released from its obligations under this letter agreement.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>No Fiduciary Duty. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Issuers and the Guarantor hereby acknowledge that (a)&nbsp;the purchase and sale of the Securities pursuant to this
Agreement is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Issuers and the Guarantor, on the one hand, and the Underwriters and any affiliate through which they may be acting, on the other,
(b)&nbsp;the Underwriters are acting as principal and not as an agent or fiduciary of the Issuers and the Guarantor and (c)&nbsp;the engagement of the Underwriters by the Issuers and the Guarantor in connection with the offering and the process
leading up to the offering is as independent contractors and not in any other capacity. Furthermore, each of the Issuers and the Guarantor agrees that it is solely responsible for making its own judgments in connection with the offering
(irrespective of whether any of the Underwriters has advised or is currently advising the Issuers or the Guarantor on related or other matters). Each of the Issuers and the Guarantor agrees that it will not claim that the Underwriters have rendered
advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Issuers and the Guarantor, in connection with such transaction or the process leading thereto. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I><FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Notwithstanding and to the exclusion of any other term of this Agreement or any other agreement,
arrangement, or understanding between or among the Issuers and the Guarantors and an Underwriter incorporated in the EU (the &#147;<B><U>Relevant BRRD Party</U></B>&#148;), the Issuers and the Guarantor acknowledge and accept that a BRRD Liability
arising under this Agreement may be subject to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority, and acknowledges, accepts and agrees to be bound by: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the effect of the exercise of <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority in relation to any BRRD Liability of the Relevant BRRD Party to the Issuers or the Guarantor, as applicable, under this Agreement, that (without limitation) may
include and result in any of the following, or some combination thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other
obligations of the Relevant BRRD Party or another person, and the issue to or conferral on the Issuers or the Guarantor of such shares, securities or obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the cancellation of the BRRD Liability; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the amendment or alteration of any interest, if applicable, thereon or the dates on which any payments are
due, including by suspending payment for a temporary period; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the variation of
the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) For purposes of this Section&nbsp;16(a): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U><FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation</U>&#148; means in relation to a member
state of the European Economic Area which has implemented, or which at any time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation
Schedule from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U><U> </U><U>Powers</U>&#148; means any Write-down
and Conversion Powers as defined in the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule, in relation to the relevant <FONT STYLE="white-space:nowrap">Bail-In</FONT> Legislation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>BRRD</U>&#148; means Directive 2014/59/EU establishing a framework for the recovery and resolution
of credit institutions and investment firms, as amended or superseded; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>BRRD</U><U> </U><U>Liability</U>&#148; means a liability in respect of which the relevant
Write-down and Conversion Powers in the applicable <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation may be exercised; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule</U>&#148; means the
document described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
http://www.lma.eu.com/pages.aspx?p=499; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>Relevant</U><U> </U><U>Resolution</U><U> </U><U>Authority</U>&#148; means the resolution authority
with the ability to exercise any <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in relation to the Relevant BRRD Party. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Notwithstanding and to the exclusion of any other term of this Agreement or any other agreement,
arrangement, or understanding between or among the Issuers and the Guarantor and an Underwriter incorporated in the UK (the &#147;<B><U>Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party</U></B>&#148;), the Issuers and the Guarantor
acknowledge and accept that a UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability arising under this Agreement may be subject to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution
Authority, and acknowledges, accepts and agrees to be bound by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the effect of the exercise of UK <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution Authority in relation to any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability of any Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party to the
Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the reduction of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability or
outstanding amounts due thereon; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion of all, or a portion, of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability
into shares, other securities or other obligations of the Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party or another person, and the issue to or conferral on the Issuers or the Guarantor of such shares, securities or obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the cancellation of the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the amendment or alteration of any interest, if applicable, thereon or the dates on which any payments are
due, including by suspending payment for a temporary period; and </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the variation of
the terms of this Agreement, as deemed necessary by the Relevant UK Resolution Authority, to give effect to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant UK Resolution Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) For purposes of this Section&nbsp;16(b): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>Relevant</U><U> </U><U>UK</U><U> </U><U>Resolution</U><U> </U><U>Authority</U>&#148; means the
resolution authority with the ability to exercise any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in relation to any Relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>UK</U><U> </U><U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U><U>
</U><U>Legislation</U>&#148; means Part I of the UK Banking Act 2009 and any other law or regulation applicable in the UK relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates
(otherwise than through liquidation, administration or other insolvency proceedings); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>UK</U><U> </U><U><FONT STYLE="white-space:nowrap">Bail-in</FONT></U><U> </U><U>Liability</U>&#148;
means a liability in respect of which the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers may be exercised; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<U>UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers</U>&#148; means the powers under the UK <FONT
STYLE="white-space:nowrap">Bail-In</FONT> Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or affiliate of a bank or investment firm, to cancel, reduce, modify or change the form of a liability of
such a person or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to
have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) The provisions of this Section&nbsp;16 shall remain in full force and effect notwithstanding completion and
shall survive the termination or cancellation of this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Jurisdiction. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Issuers and the Guarantor agrees that any suit, action or proceeding against the Issuers or the
Guarantor brought by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, arising out of or based upon this Agreement or the offer and sale of the Securities
contemplated hereby may be instituted in any State or Federal court in The City of New York, New York, and waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any suit, action or proceeding. Each of the Issuers and the Guarantor has appointed Teva Pharmaceuticals USA, Inc. (&#147;<B><U>Teva USA</U></B>&#148;) as its authorized
agent (the &#147;<B><U>Authorized Agent</U></B>&#148;) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated herein which may be instituted in any State or
Federal court in The City of New York, New York, by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, and expressly accepts the <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of any such court in respect of any such suit, action or proceeding. Each of the Issuers and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such
appointment and has agreed to act as said agent for service of process, and each of the Issuers and the Guarantor agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in
full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Issuers or the Guarantor, as applicable. Notwithstanding the foregoing, any action arising out
of or based upon this Agreement may be instituted by any Underwriter, the directors, officers, employees, agents and affiliates of any Underwriter, or by any person who controls any Underwriter, in any court of competent jurisdiction in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Israel. EACH OF THE ISSUERS, THE GUARANTOR AND EACH OF THE UNDERWRITERS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OFFER AND SALE OF THE SECURITIES CONTEMPLATED HEREBY. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Applicable Law. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts
made and to be performed within the State of New York. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Currency. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each reference in this Agreement to U.S. dollars (the &#147;<B><U>relevant</U></B><B> </B><B><U>currency</U></B>&#148;) is of
the essence. To the fullest extent permitted by law, the obligations of each of the Issuers and the Guarantor in respect of any amount due under this Agreement will, notwithstanding any payment in any other currency (whether pursuant to a judgment
or otherwise), be discharged only to the extent of the amount in the relevant currency that the party entitled to receive such payment may, in accordance with its normal procedures, purchase with the sum paid in such other currency (after any
premium and costs of exchange) on the Business Day immediately following the day on which such party receives such payment. If the amount in the relevant currency that may be so purchased for any reason falls short of the amount originally due, the
Issuers and the Guarantor will pay such additional amounts, in the relevant currency, as may be necessary to compensate for the shortfall. Any obligation of each of the Issuers or the Guarantor not discharged by such payment will, to the fullest
extent permitted by applicable law, be due as a separate and independent obligation and, until discharged as provided herein, will continue in full force and effect. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Recognition of the U.S. Special Resolution Regimes</I></B><B></B><B><I>.</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) In the event that any Underwriter that is a Covered Entity (as defined below)
becomes subject to a proceeding under a U.S. Special Resolution Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the
transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of
such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against such Underwriter are permitted to be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of
the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) For purposes of this Section&nbsp;20: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(1) &#147;<U>BHC Act Affiliate</U>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and
shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(2) &#147;<U>Covered Entity</U>&#148;
means any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&#167; 252.82(b), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b), or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b); </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(3) &#147;<U>Default Right</U>&#148; has the meaning assigned to that term in,
and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(4) &#147;<U>U.S. Special Resolution Regime</U>&#148; means each of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) the Federal Deposit Insurance Act and the regulations promulgated thereunder, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated
thereunder. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Waiver of Immunity. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the extent that either of the Issuers or the Guarantor has or hereafter may acquire any immunity (sovereign or otherwise)
from any legal action, suit or proceeding, from jurisdiction of any court or from <FONT STYLE="white-space:nowrap">set-off</FONT> or any legal process (whether service or notice, attachment in aid or otherwise) with respect to itself or any of its
property, each of the Issuers and the Guarantor hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its obligations under this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Definitions.</I></B><B></B><B><I> </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The terms which follow, as used in this Agreement, have the meanings </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
indicated: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Base Prospectus</U>&#148; means the prospectus
contained in the Registration Statement at the Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Business</U><U> </U><U>Day</U>&#148; means any day
on which the New York Stock Exchange is open for trading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Disclosure Package</U>&#148; shall mean (i)&nbsp;the
Base Prospectus, as amended and supplemented to the Execution Time, (ii)&nbsp;the Issuer Free Writing Prospectuses, if any, identified in Schedule II hereto, and (iii)&nbsp;any other Free Writing Prospectus that the parties hereto shall hereafter
expressly agree in writing to treat as part of the Disclosure Package other than a road show that is an Issuer Free Writing Prospectus under Rule 433 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Effective</U><U> </U><U>Time</U>&#148; means each date and time that the Registration Statement and any post-
effective amendment or amendments thereto became or become </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">effective </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Execution Time</U>&#148; means (i) 11:35 A.M. (New York time) on March&nbsp;1, 2023 for the Euro Securities and (ii)
11:38 A.M. (New York time) on March 1, 2023 for the Dollar Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Free</U><U> </U><U>Writing</U><U>
</U><U>Prospectus</U>&#148; shall mean a free writing prospectus, as defined in Rule 405 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Incorporated</U><U> </U><U>Documents</U>&#148; means documents that are incorporated into any of the Registration
Statement, Prospectus or Preliminary Prospectus by reference. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Issuer</U><U> </U><U>Free</U><U>
</U><U>Writing</U><U> </U><U>Prospectus</U>&#148; shall mean an issuer free writing prospectus, as defined in Rule 433 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Ordinary</U><U> </U><U>Shares</U>&#148; shall mean fully paid, nonassessable ordinary shares of the Guarantor, par
value NIS 0.10 per share, or American Depository Shares representing such ordinary shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Preliminary
Prospectus</U>&#148; shall mean any preliminary prospectus supplement to the Base Prospectus which describes the Securities and the offering thereof and is used prior to filing of the final Prospectus, together with the Base Prospectus and any
Incorporated Documents with respect thereto </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Prospectus</U>&#148; means the prospectus and prospectus supplements
first filed after the Execution Time with the Commission by the Issuers and the Guarantor with the consent of the Representatives pursuant to Rule 424(b) of the Rules and Regulations relating to the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>Registration</U><U> </U><U>Statement</U>&#148; means the Registration Statement of the Issuers and the Guarantor filed
with the Commission on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-260519),</FONT> including any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) of the
Rules and Regulations and deemed part of such registration statement pursuant to Rule 430B of the Rules and Regulations, exhibits other than Forms <FONT STYLE="white-space:nowrap">T-1</FONT> and financial statements, as amended at the Execution Time
and, in the event any post-effective amendment thereto becomes effective prior to the Delivery Date, means also such registration statement as so amended </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<U>subsidiary</U>&#148; has the meaning set forth in Rule 405 of the Rules and Regulations. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Compliance with USA Patriot Act. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Issuers and the Guarantor acknowledge that, in accordance with the requirements of Title III of the Uniting and
Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Pub. L <FONT STYLE="white-space:nowrap">107-56)</FONT> (USA PATRIOT Act) (signed into law October&nbsp;26, 2001), the Underwriters are
required to obtain, verify and record information that identifies their respective clients, including the Issuers and the Guarantor, which information may include the name and address of their respective clients, as well as other information that
will allow the Underwriters to properly identify their respective clients. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Counterparts. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed
counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Headings. </I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning
or interpretation of, this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B></B><B><I>Electronic Signatures.</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Agreement may be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without
limitation, facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Agreement may be executed by one or more parties to this Agreement in any number of
separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same instrument and any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes to the fullest extent permitted by applicable law. For the avoidance of doubt, the authorization under this Section&nbsp;26&nbsp;may include, without
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
limitation, a manually signed paper communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed communication converted into another
format, for transmission, delivery and/or retention. For the avoidance of doubt, the foregoing also applies to any amendment, extension or renewal of this Agreement. Each of the parties represents and warrants to the other party/ies that it has the
corporate capacity and authority to execute this Agreement through electronic means and there are no restrictions for doing so in that party&#146;s constitutive documents. For purposes hereof, &#147;Electronic Record&#148; and &#147;Electronic
Signature&#148; shall have the meanings assigned to them, respectively, by 15 USC &#167;7006, as it may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature pages follow) </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the foregoing correctly sets forth the agreement between the Issuers, the
Guarantor and the Underwriters, please indicate your acceptance in the space provided for that purpose below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Amir Weis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Amir Weis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Senior Vice President and Chief Accounting Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Executive Vice President and Chief Financial Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Representative</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Representative</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Representative</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Representative</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Citigroup Global Markets Europe AG Goldman Sachs Bank Europe SE Mizuho Securities Europe GMBH</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MUFG Securities (Europe) N.V.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PNC Capital Markets LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Euro Representatives and Euro Underwriters</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CITIGROUP GLOBAL MARKETS EUROPE AG</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Tim Patzold</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tim Patzold</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Senior Counsel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Adrien Belanger</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adrien Belanger</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Delegated Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">GOLDMAN SACHS BANK EUROPE SE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Kim Salvadori</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kim Salvadori</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Jonathan Brennan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jonathan Brennan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MIZUHO SECURITIES EUROPE GMBH</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Christoph Seibel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Christoph Seibel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chief Executive Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Peter Krafft</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Peter Krafft</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chief Financial Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MUFG SECURITIES (EUROPE) N.V.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Jeff Simmons</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jeff Simmons</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorised Signatory</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PNC CAPITAL MARKETS LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Valerie Shadeck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Valerie Shadeck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Managing Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Citigroup Global Markets Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Goldman Sachs Bank Europe SE</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mizuho Securities USA LLC</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MUFG Securities Americas Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PNC Capital Markets LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Dollar Representatives and Dollar Underwriters</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CITIGROUP GLOBAL MARKETS INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">GOLDMAN SACHS BANK EUROPE SE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Kim Salvadori</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kim Salvadori</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Jonathan Brennan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jonathan Brennan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MIZUHO SECURITIES USA LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Seth Nadler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Seth Nadler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MUFG SECURITIES AMERICAS INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Brian Cogliandro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brian Cogliandro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PNC CAPITAL MARKETS LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Valerie Shadeck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Valerie Shadeck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Managing Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BNP Paribas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BofA Securities Europe SA</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HSBC Bank plc</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Intesa Sanpaolo S.p.A.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">J.P. Morgan SE</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Euro Underwriters</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BNP PARIBAS</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Vikas Katyal</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Vikas Katyal</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Authorised Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Chiara Picarelli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Chiara Picarelli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Authorised Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BOFA SECURITIES EUROPE SA</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Astghik Khachatryan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Astghik Khachatryan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HSBC BANK PLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ A Kraemer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: A Kraemer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Senior Legal Counsel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">INTESA SANPAOLO S.P.A.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Silvio Capone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Silvio Capone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Davide Vietri</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Davide Vietri</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Authorised Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">J.P. MORGAN SE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Natalia Lutova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Natalia Lutova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Executive Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BNP Paribas Securities Corp.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BofA Securities, Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HSBC Bank plc</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Intesa Sanpaolo S.p.A.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">J.P. Morgan SE</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">as Dollar Underwriters</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BNP PARIBAS SECURITIES CORP.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Roger Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Roger Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">BOFA SECURITIES, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Matt Curtin</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Matt Curtin</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HSBC BANK PLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ A Kraemer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: A Kraemer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Senior Legal Counsel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">INTESA SANPAOLO S.P.A.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Silvio Capone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Silvio Capone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Davide Vietri</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Davide Vietri</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Authorised Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">J.P. MORGAN SE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Natalia Lutova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Natalia Lutova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name: Ales Mydlar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title: Executive Director</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Signature Page to
Underwriting Agreement)</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Part A </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Euro Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2029 Euro Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS EUROPE AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES EUROPE GMBH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES (EUROPE) N.V</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES EUROPE SA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">800,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Euro Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2031 Euro Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS EUROPE AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES EUROPE GMBH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES (EUROPE) N.V</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES EUROPE SA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Part B </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Dollar Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2029 Dollar Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS SECURITIES CORP.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Dollar Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of</B><br><B>2031 Dollar Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS BANK EUROPE SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP PARIBAS SECURITIES CORP.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC BANK PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTESA SANPAOLO S.P.A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Final Term Sheet dated March 1, 2023 as filed with the Commission pursuant to Rule 433 of the Rules and Regulations. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d422149dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g422149dsp60b.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right">


<IMG SRC="g422149dsp60a.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior
Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Proceeds to Repay Existing Debt </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TEL AVIV&#151;(BUSINESS WIRE)&#151;<B>March</B><B></B><B>&nbsp;1</B><B>, 2023</B>&#151; Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
TEVA) (&#147;<B>Teva</B>&#148;) announced today that it successfully upsized its offering and priced approximately $2,490,000,000 (equivalent) of its sustainability-linked senior notes (the &#147;<B>Notes</B>&#148;). The principal amount of the
offering was increased from the previously announced offering size of $2,060,000,000 (equivalent) and the maximum tender amount of Teva&#146;s previously announced debt tender offer was increased from $2,250,000,000 to $2,500,000,000. Teva expects
to use the net proceeds from the offerings (i)&nbsp;to fund the announced tender offers to purchase, for cash, its 7.125% Senior Notes due 2025, 6.000% Senior Notes due 2025, 4.500% Senior Notes due 2025, 2.800% Senior Notes due 2023, 6.000% Senior
Notes due 2024 and 3.150% Senior Notes due 2026 for a maximum combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,500,000,000 (as it may be amended prior to expiration thereof), (ii) to pay fees and expenses in
connection therewith and (iii)&nbsp;to the extent of any remaining proceeds, the repayment of outstanding debt upon maturity, tender offer or earlier redemption. Net proceeds may be temporarily invested pending application for their stated purpose.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This is Teva&#146;s second offering of Sustainability-Linked Senior Notes. The transaction demonstrates Teva&#146;s continued strong
commitment to sustainable finance and is tied to targets that include improving access to Teva&#146;s portfolio of medicines in <FONT STYLE="white-space:nowrap">low-</FONT> and middle-income countries (LMICs) and reducing Teva&#146;s absolute
greenhouse gas (GHG) emissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes consist of (i)&nbsp;Teva Pharmaceutical Finance Netherlands II B.V.&#146;s (&#147;<B>Teva
Finance II</B>&#148;) &#128;800,000,000 aggregate principal amount of 7.375% <FONT STYLE="white-space:nowrap">EUR-denominated</FONT> Sustainability-Linked Senior Notes maturing in 2029, (ii) Teva Finance II&#146;s &#128;500,000,000 aggregate
principal amount of 7.875% <FONT STYLE="white-space:nowrap">EUR-denominated</FONT> Sustainability-Linked Senior Notes maturing in 2031, (iii) Teva Pharmaceutical Finance Netherlands III B.V.&#146;s (&#147;<B>Teva Finance III</B>&#148; and, together
with Teva Finance II, the &#147;<B>Issuers</B>&#148;) $600,000,000 aggregate principal amount of 7.875% <FONT STYLE="white-space:nowrap">USD-denominated</FONT> Sustainability-Linked Senior Notes maturing in 2029 and (iv)&nbsp;Teva Finance III&#146;s
$500,000,000 aggregate principal amount of 8.125% <FONT STYLE="white-space:nowrap">USD-denominated</FONT> Sustainability-Linked Senior Notes maturing in 2031. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The settlement of the Notes is expected to occur on or about March 9, 2023, subject to customary closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes will be unsecured senior obligations of the Issuers and will be unconditionally guaranteed on a senior unsecured basis by Teva. The
offering and sale of the Notes were made pursuant to our effective automatic shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> including our base prospectus, filed with the Securities and Exchange Commission (the
&#147;<B>SEC</B>&#148;) on October&nbsp;27, 2021. The offering of these Notes was made only by means of a prospectus supplement and accompanying base prospectus, which have been filed with the SEC. Before you invest, you should
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
read the prospectus supplement and accompanying prospectus along with other documents that Teva has filed with the SEC for more complete information about Teva and this offering. These documents
are available at no charge by visiting EDGAR on the SEC website at http://www.sec.gov. Alternatively, a copy of the prospectus supplement and accompanying base prospectus related to this offering may be obtained, when available, by contacting
Citigroup Global Markets Europe AG, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, United States (Tel: +1 (800) <FONT STYLE="white-space:nowrap">831-9146,</FONT> <FONT STYLE="white-space:nowrap">e-mail:</FONT>
prospectus@citi.com); Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, United States (Tel: +1 (800) <FONT STYLE="white-space:nowrap">831-9146,</FONT>
<FONT STYLE="white-space:nowrap">e-mail:</FONT> prospectus@citi.com); Goldman Sachs Bank Europe SE, Marienturm, Taunusanlage <FONT STYLE="white-space:nowrap">9-10,</FONT> 60329 Frankfurt am Main, Germany, Attention: High Yield Syndicate Desk (Tel:
+49 69 7532 1000, Fax: +44 (0)207 774 2330); Mizuho Securities Europe GMBH, Taunustor 1, 60310 Frankfurt am Main, Germany, Attention: Primary Debt (Tel: +49 69 42729 3140, email: <FONT STYLE="white-space:nowrap">PrimaryDebt@eu.mizuho-sc.com);</FONT>
Mizuho Securities USA LLC, 1271 Avenue of the Americas, New York, NY 10020, United States, Attention: Debt Capital Markets (Fax: +1 (212) <FONT STYLE="white-space:nowrap">205-7812);</FONT> MUFG Securities (Europe) N.V., World Trade Center, Tower H,
11th Floor, Zuidplein 98, 1077 XV Amsterdam, The Netherlands, Attention: Legal-Primary Markets (email: Legal-primarymarkets@int.sc.mufg.jp); MUFG Securities Americas Inc., 1221 Avenue of the Americas, New York, NY 10020-1001, United States,
Attention: Capital Markets Group (Phone: +1 877 649 6848); or PNC Capital Markets LLC, 10th Floor, 300 Fifth Avenue, Pittsburgh, PA 15222, Unites States, Attention: Securities Settlement, toll-free <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">855-881-0697</FONT></FONT> or by email: pnccmprospectus@pnc.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This press release shall not constitute an
offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>About Teva </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people&#146;s lives for more
than a century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200&nbsp;million people around the world take a Teva medicine every day, and are
served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative medicines research and operations supporting our growing portfolio of
innovative medicines and biopharmaceutical products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are
based on management&#146;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed
or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: completion of the offering of senior notes and tender offer for certain outstanding notes; our substantial
indebtedness, which may limit our </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>
ability to incur additional indebtedness, engage in additional transactions or make new investments, and may result in a further downgrade of our credit ratings; our inability to raise debt or
borrow funds in amounts or on terms that are favorable to us; and other factors discussed in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, including the sections thereof captioned
&#147;Risk Factors&#148; and &#147;Forward Looking Statements&#148; and other filings with the SEC, which are available at www.sec.gov. Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to
update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. No assurance
can be given that the transactions described herein will be consummated or as to the ultimate terms of any such transactions. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">It may
be unlawful to distribute this press release in certain jurisdictions. This press release is not for distribution in Canada, Japan or Australia. The information in this press release does not constitute an offer of securities for sale in Canada,
Japan or Australia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or
otherwise made available to any retail investor in the European Economic Area (&#147;<B>EEA</B>&#148;). For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article
4(1) of Directive 2014/65/EU (as amended, &#147;<B>MiFID II</B>&#148;); or (ii)&nbsp;a customer within the meaning of Directive 2016/97/EU (as amended, the &#147;<B>Insurance Distribution Directive</B>&#148;), where that customer would not qualify
as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or (iii)&nbsp;not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129. Consequently no key information document required by Regulation (EU) No
1286/2014 (as amended, the &#147;<B>PRIIPs Regulation</B>&#148;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making
them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Promotion of the Notes in the United
Kingdom is restricted by the Financial Services and Markets Act 2000 (the &#147;<B>FSMA</B>&#148;), and accordingly, the Notes are not being promoted to the general public in the United Kingdom. This announcement is for distribution only to, and is
only directed at, persons who (i)&nbsp;persons who are outside the United Kingdom or (ii)&nbsp;investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the
&#147;<B>Order</B>&#148;), (iii) high net worth entities, and other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (d)&nbsp;of the Order or (iv)&nbsp;persons to whom an invitation or inducement to engage in
investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as
&#147;<B>relevant persons</B>&#148;). The Notes will only be available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Notes will be engaged in only with, relevant persons. This announcement is directed
only at relevant persons and must not be acted on or relied on by anyone who is not a relevant person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes have not, may not and
will not be offered, sold or delivered in the Netherlands, other than to qualified investors (as defined in Regulation (EU) 2017/1129). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes have not, may not and will not be offered, sold or delivered in Israel, other than
to persons who qualify as one of the types of investors listed in the First Addendum to the Israeli Securities Law, subject to and in accordance with the requirements set forth in the First Addendum to the Israeli Securities Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contacts </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">IR Contacts:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Ran Meir</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">United States</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(267) <FONT STYLE="white-space:nowrap">468-4475</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Yael Ashman</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Israel</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">972 (3) <FONT STYLE="white-space:nowrap">914-8262</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PR Contacts:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Kelley Dougherty</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">United States</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(973) <FONT STYLE="white-space:nowrap">832-2810</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Eden Klein</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Israel</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">972 (3) <FONT STYLE="white-space:nowrap">906-2645</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>teva-20230301.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/3/2023 4:56:05 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:teva="http://www.tevapharm.com/20230301"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tevapharm.com/20230301"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230301_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230301_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>teva-20230301_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/3/2023 4:56:05 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>teva-20230301_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/3/2023 4:56:05 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="teva-20230301.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g422149dsp60a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g422149dsp60a.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @,# @(# @(" P0# P,#! 0$ @,$! 0$! ,$! ,! @(" @(" @(" @,"
M @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# __$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M^+]J3X[-U\=9Q_U+/@X=/IX>K%\0YPO^8NUO^G5'_P"5GITO$WCEM<V=Z?\
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M3'?\_P#_ ,DI_P#R!,GQ9^(!ZZ_Z_P#,*T0=/^X;2EQCQ&G_ ,C&W_<OA?\
MY04LSQU_X_\ Y)3_ /D#VKX1>+-?\3_\)!_;M_\ ;OL/]D_9?]%LK;ROM/\
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M[?A_2@U1/'_C2EN6MT?1WP#_ .9K_P"X%_[F:_3?#K_F<?\ <I_[LGT&2_\
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M0:HGC_QI2W+6Z/H[X!_\S7_W O\ W,U^F^'7_,X_[E/_ '9/H,E_YB?^X?\
M[>?1%?IA[@4 % !0 4 % !0 4 % !0 4 % !0 4 % "$<8Z8_#I1^%@MT(VC
M#<=N>.#UI6757ML)I/=7ML?+GQL^"EKKMK<^)O#MNL&LV\;S75K"HVWT48+N
M5C49,^T/@ \G  S7QG$7#T,32EB\+#EK0O)Q2WMJ?$<3<.0Q5*>*PD+5Z=Y.
M*^U;73S/A2:WGM)7MYXI()H6*212HT<B,IP0R. 5/U%?F+A.G*4:B<9Q>J>E
MG\S\L]E4A)PFG&2>J:LTUI:S!1C';'X8Q63MJGHUL5%<BM\+6QKV=T4Q'(?E
MZ*Q[=L&H>AZ.'K67)+2QO1D8&.GY]JYW>YZ46E:S+"?EC\.E-:(T73I8M1_T
M_P :CJCHCL6HNU,V@6$[TC6.Y93M2>QK'XD64_H?YU!LMRVO;\/Z4&J)X_\
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MH-43Q_XTI;EK='T=\ _^9K_[@7_N9K]-\.O^9Q_W*?\ NR?09+_S$_\ </\
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M _\ F:_^X%_[F:_3?#K_ )G'_<I_[LGT&2_\Q/\ W#_]O/HBOTP]P* "@ H
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MR7_F)\O9_P#MY]$5^FGN!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 ,(Y_#_ #Q2^U_A5UZ[!LK;+^D?('QI\.II?B&+4[=
ML&J1%W51A4GB"(WXNVYC7X]QMEWU;,(8F*M"O&[[<VE_U/E,YPWL:T)Q5E)'
MC:KSTZ?IBOBMOD>,M/*Q95<?THV^1JM+>1]'_L_C'_"6\8_Y /Z?VS7Z7X=:
M?VQY?5/_ '9/H,B_YBNEO9?^Y#Z.K],/?"@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@!"/PQ^'2C1-+ML%M+=$>5_%CP^-9\
M+W,T<>ZYTUA=Q8SO8(&1HQ['?G'^S7RO%N7/&Y;.4(WJ8?WT^R6_YGG9I15;
M#-VO*&W](^-E7'MC\,8XK\2>JO%<NMK>FY\>H\O,GO$D P,] .@^E3^A=K'T
M=\ /^9L[8_L'V_Z#-?IOAU_S./+ZI_[LGOY'I]:\O9_^Y#Z,K],/?"@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ _I1;\ V*
M]U"MQ;RV[@%)4:-@1D$,".E95::JTJE*2]V<6F*45*+CY'PAXMT)O#OB"_TP
MC$<4K/;]MUNS,(VQ[[37X'G>!>6XZOA[6C&5X^C=M/N/C,91=&NX]+Z'/ ?A
MBO'O;Y'/RM?(^C?@"NW_ (2S_N _I_;-?IGAS_S./+ZI_P"[)[V2*WUGI_#_
M /<A]%U^FGO!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 (1Q_GC%)_D"T/F[XX:'AM/UV%,;MUK=.!P%39Y ..Y9Y*_,.
M/,"FZ&.@OA]V6AX6;T;)5$MOT/GU5QC_ #TK\UV\K'AK[CZ,^ @V_P#"5_\
M<"_3^V*_3?#G3^V.G^Z?^[)[N2Z?6?+V?_MY]$5^FGN!0 4 % !0 4 % !0
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M)7[?V%_[F*^[\.%-?VSSVL_JG+96T_VD]?)[+ZS;I[/_ -O/H:OTX]L* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M/DSXPZ3]A\2+>HN(]3@$[,!@>:A:';]=D0-?CO&V$^K9I2JJ/+3Q4.9OS3<?
M_;;^A\WF]/EK0Y5:YUOP%X_X2KV_L+]/[8KUO#OF7]LI[+ZIR^G^TV.G)M/K
M'E[/_P!O/H:OTP]L* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * /#_ (TZ;YVBV-\H^:SNCO8#I$Z% ,^F]Z^#X[PZ
MGET<5;7#U%%>DTHK\9'E9M3O24TOA,GX"\?\)5_W OPQ_;%<'AUHLVC_ "+"
M1^:^LG/DC_WGR]G_ .Y#Z&K]+/="@ H * "@ H * "@ H * "@ H * "@ H
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MMJ$'5LI\T(6?[Q;<RT>O?CP>%EA76NTU-IJU]E?>Z7?H>F5]8=H4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g422149dsp60b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g422149dsp60b.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M^IKJC@,;)7CA:K2Z\DO\CEEC\%!\KQ5*+73GC_F=CI&OZ%KT/VC0]9TO5X
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MW,WAW0+8.3"D5C(8KNZ"9QYLURKEC_L"OO\ (,!' Y?25K5:R4YOKKLO1(^
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MTDDDLLCL>I)/Z 5_(O'&&KXSCC-<+AJ;JUZ^)C"G"*NW)QBDDCQ^&,3*?#N
MQ6)JN4I4G.I.3UNY2;;;/I3X-_%_3M(_9^\<_$FY18=,\,WGB":T5N#<?8T5
M+3>#WEN&C&!V-?TSP%PG5R#+,OR:<^?%5YJK6[1G4LY1CY02M?N?493FL*F5
M8K'6Y:5"=11\U'17]6?@GXV\7ZSX]\5:YXNU^ZDN]4UW4+B^N))7+[/-D+1P
M)G[L44>U%48 "U_1N&H4\+0I8>DN6%**BEZ=?GN?G.(KU,37J5ZKYIU)-O\
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M:O[.GRQ3JM/[<MH]D?0X/,*D>'\KRZ"=-0HIU+Z-N[:C;LMSW_Q3'?\ A?\
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M)+EHU R2S2S2?3/I7#D&)5'-Z$Y/E55R@WVYE9'ZUFN7JED#PE):82$&DO\
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MQM9/2]^\3J?V\/@(UU>VW[07P^@_M7PKXJM+2[\1MIZ>:MK<RQ*;?6-L0/\
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E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139643807820640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora Hanevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d422149d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="teva-20230301.xsd" xlink:type="simple"/>
    <context id="duration_2023-03-01_to_2023-03-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-01</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-03-01_to_2023-03-01"
      id="Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LTD</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-03-01_to_2023-03-01">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-03-01_to_2023-03-01"
      id="Hidden_dei_EntityCentralIndexKey">0000818686</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-03-01_to_2023-03-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-03-01_to_2023-03-01">2023-03-01</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-03-01_to_2023-03-01">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-03-01_to_2023-03-01">001-16174</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-03-01_to_2023-03-01">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-03-01_to_2023-03-01">124 Dvora Hanevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-03-01_to_2023-03-01">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-03-01_to_2023-03-01">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2023-03-01_to_2023-03-01">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2023-03-01_to_2023-03-01">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-03-01_to_2023-03-01">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-03-01_to_2023-03-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-03-01_to_2023-03-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-03-01_to_2023-03-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-03-01_to_2023-03-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-03-01_to_2023-03-01">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-03-01_to_2023-03-01">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-03-01_to_2023-03-01">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-03-01_to_2023-03-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M@3AC5C/NHG%G!   N!   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF-%NXC@4AE_%RDASU4[BE +M !(%ND5#6U3HC'97>V$20ZQ)[*QCH'W[/4YH
MPJKA!"Y*'.P_7\[Q^6VWMU?Z=Q9Q;LA;$LNL[T3&I+>NFP413UCV3:5<PB]K
MI1-FH*DW;I9JSL)\4!*[ON>UW80)Z0QZ^;VY'O34UL1"\KDFV39)F'Z_X[':
M]QWJ?-QX$9O(V!ONH)>R#5]P\YK.-;3<4B44"9>94))HONX[0WI[Y[?L@+S'
M3\'WV=$UL:^R4NJW;4S#ON-9(A[SP%@)!E\[/N)Q;)6 X]^#J%,^TPX\OOY0
MO\]?'EYFQ3(^4O$O$9JH[W0=$O(UV\;F1>T?^.&%KJU>H.(L_TOV1=^6YY!@
MFQF5' 8#02)D\<W>#H$X&M"^/C' /PSP<^[B03GEF!DVZ&FU)]KV!C5[D;]J
M/AK@A+1961@-OPH89P9C%6PAR(8P&9*)-,*\DZDLL@U1Z[D&'F*[NL%!\*X0
M]$\(/C+]C7CT@OB>?_7_X2ZPE8!^">CG>E<G]$9JQS7Y>[C*C(84_E-'5"BT
MZA7LO+[-4A;PO@,3-^-ZQYW!UR^T[7U'^*Y*OBM,?7"(V0O?"$L(D7QB":^C
MQ'66DY]#,G\8OCP.1Y/7Y70TG)'IT_AUL7R93A9DMAPCL*T2MH4^9 BI#O-T
MW\=L4P>)CU^S..,(QW7)<7U.T$9 HED,$R[D;^0'?Z\CPI4\^'1IM]UM(UCM
M$JN-BI7%L'Q/:U.(#^]>_D @.B5$YSR(.=="V:(,"91V+0^NE)=B7HM-Q=@M
MV;KGY&TJ Z53I7.+( L#=&2DMI!,R*D*:U%QX1E&=U/2W9Q#=R]B3IZVR8KK
M.A!<P_/H)6W33@OAH5YEKMXY1$OV1J8AY%2L15 $[31?@Z3G77K%!R,\LG]Z
M#N$P#,$:LXN/"S*#?N19UJ:R09+Z+3+>P>P@#TSRG?CZI>O3SG<&$T7#,H5A
M5XL"13W]$_;(MI0F2[6O7[-PN26/R7 G=AA;M2#0LU:$DFVN,@,F]Y=(3Q9'
M@V+[IM7R?#3AU0I <0O_%+FB;FNI<*7I# .JE@**.WB>NB'L*$]'!Q>XZ?@8
M2&7^%+?OF0H@3?-(2<P^&D2N+F]HZQ(F/&9HM%H+*&[AO[0PADL(39)LY<$\
MLEHN7*AIY:;5$D!QJUZH6 3""+DACV#\6K"XE@=7:>2I3)_BCCW7/ \/EP$O
M%F_8X\"6\7F]/I%!7*^)S*_<W\>M^A/9-,NV0-8$V"#;"%B9OX\[]8('6VW+
MC_HKLA0FKBV_!A'84VJ8F)*,>:HR8>!L1Q81 W>Y()P%$9S=\FVWS*>,+:YG
M'0I9=L/>Y.B0T&#@FH56?O&>K%3M?&P2@.TW1E*YOX][=1G3R5L0,;GA)\\#
M#4)/?RXF&%'E^/Y9CC^!/&ULC/X !1/9F9DR66O\#8(G)Z![= ZU9WK8@,(3
M,Q+S-0AYWSI@Y+HX)A<-H]+\:+I2!@ZZ^67$&12'[0"_KY4R'PU[VBW_63'X
M#U!+ P04    " "!.&-6GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=
M5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=
MA['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6
M,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?
MRA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C
M$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M
M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#
ME_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\
M;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!
MI!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,
MD_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?
M\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>
M\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O
M&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R
M^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%N
MV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@/
M/GL?)=-[*CG_5U/\!%!+ P04    " "!.&-6EXJ[',     3 @  "P   %]R
M96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:
MI7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$
MVV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_
M,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH
M^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ($X8U8<.&7J/P$  #P"
M   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0JA:5
MBON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6I;(&
M;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$[( =
MPCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z,@QV
M0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,PS/%
MML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*/:XH
M$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:HPQH;0?AHUH+%0:P;W(@"2[)E1M2
M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "!.&-6)!Z;HJT
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M2P$"% ,4    " "!.&-6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ($X8U;9)A-O[0   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M ($X8U:97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ @3AC5C/NHG%G!   N!   !@
M     ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M ($X8U:?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ @3AC5I>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ @3AC5APX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ($X
M8U8D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ($X8U9ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d422149d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d422149d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d422149d8k.htm">d422149d8k.htm</File>
    <File>d422149dex11.htm</File>
    <File>d422149dex991.htm</File>
    <File>teva-20230301.xsd</File>
    <File>teva-20230301_lab.xml</File>
    <File>teva-20230301_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d422149d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d422149d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "teva-20230301_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "teva-20230301_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "teva-20230301.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "teva",
   "nsuri": "http://www.tevapharm.com/20230301",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d422149d8k.htm",
      "contextRef": "duration_2023-03-01_to_2023-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d422149d8k.htm",
      "contextRef": "duration_2023-03-01_to_2023-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-23-058966-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-058966-xbrl.zip
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MV2"UL6*U&>*UUUSS/9XSTWRKJA[-L;XP;2KE>VVQOA2=^\:=H"C&>HNT/YM
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M!.&\ UV,$$*E7";?AQ@ 04(W9,P'W">-1LE ?:Z<B'8@!)ZF# ];(K6V+9;
M@AD>UX7#7."],3Q'IH^28>0AF#\K/7,(;F4ATJM(? ^XX$[\BB$$2*T918R@
M="G04VA!T $UT&G D$3#0#A<CG7]QP*Q],.AY9N7ER\R2'@[YA%\3([!2U%&
M?<" X. K6-$30VXS*^RLC#F88 CLF"H]3)O@DPU]S0)2GTZTQY"$+MDYAL^!
M.35\/ E>BL+ :/$K7!"MR&UA"<R$6FR1$>-LMP8\[8Z'F8?E;#C$KU.3>?J
M(O,1&>#,P-#A:44S#8,,0)@U$$NLEF";K3V.#],4'R'2 C^W4"<E?&?-]V69
ME@S1K8HF.WAF7*Y9('G!3LH>C=.E<N(9/(A+M$&Q@&[KDL^E7TL8VRH15\]%
M';O=2,JW&?#Y$:,AE5[SW9$.WE7<L="S0!*J1V]+RJ16+"1UAM)9HX!B).2*
M E&.IU)#H(B!ADJE/ E=)$)'@JG]NI1V^Y;LTHJZQ#,J$-O0"@%:X)$OM@NA
M(Z+]@8'5Z@3"]4 -?2FL[M-US%*!? '6 :*1/AA:23Y3YR%ZN-\ID&O^1S!V
M4QI:-WZY_OPUJ_E;OT6NKMK0].WR2\HWT \>D!N@QG)SF ?44"EBW-VT29MZ
MW$^ K$:F<IX4I%B^+I6A0=3%: 7:J*!=Y5/PM8469D+08CILBN8PM)29"$\0
MMA#&DLJ8AI.XN VM[2"UE;%8X!0T7#! [:A^>E*I%"KZ?T4K'3H"4HXP@/;B
M0GPZP1@6'SLNU8X/?R9]\-HHC#< >^#/BE?<>0"@^\SA ,.-Z\.2K8"A;#52
M2U W$-&Z4\IHAQ =SB':#*"3K0"J&0L P8T5 +T LPJU?SMZVR5DX?1;_R)C
M!7]+(),\#\1)R:B^%H^+0(1:)Z6T\)DTQ(7YO3DAM+H;AS/-[Z>4W%P\HU67
M"#JEBCC+OAMXG6SJZ80/B!;&2@P]<F4*-*$:VA[H812U$X'$(HA/5*I8 ]U_
MGX"+40(O(^J\+%]ZABS<9PT.  ZBP&,5."G,; 1.DA]60Y(>=Q-(DO1\'I!E
MX7@6(_-1-T3(IF LJ9EGT;$*C'V$7(O+3G#X$TV5@:RL-PXS]"L#E\4((K(U
M*A2-8C<5B203F GW(CY"$YVJ40&B.GRM_(B-X^!^L=;J]Z)0.*]/%;LE3;):
MK5:L'E4.C<9!K"] :6/\X@<R/*P3&5.>CARS 9LO5<6)BX%6K,$2X2B>TS9]
M=\"$!JIZK'2(4<@"20:>9VL4J$Q#F+) 4U\@EHK]+ME @%\V2XU6TZ-IH%9
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M87TJ$XPMY1B_L3ZN3B.V"I K^0#IC6P5H"J;9(LXD2L SI\7)2E"?6B62CP
MF4,G'N#6U%_]*PT*#D9QY >5*WZ?+ MK>? E_\)#6";]IWB0L%:,7W6?%P>B
MF # SP7%)I=L_0G7)7^%%_,'QB:03TCHR<N77$9P=W<Q33/4L7!DL.GA();;
ML*)\=O3V*PC[_"0)=B<4E-I^^?@)6;"T:WA3._)J_:*M9*>UO./F%]XXH97O
MFX\(J)ULL]2FS%HN?FP1PV:PEY08?0LF[ 132)1I8E'I6"0)DTXK;F<=G$^0
MC"F:72C@\FE:DO(&ST-IVW%27R1);AL+77:/8VG TR9)F:=B/M$MA;85$67Z
MP@QIM4[$VMV+:S?HW&ZCC=7!T^ST:78".0TW4JE%ZC;X9]!5JZ6KK^3'3_YN
M-G6\W_CP*2AGNTI+73 K7>"][4U&R#2_M+_16>'5J$8+;FKLO K:M(>209SX
M0R=*4^1 8G]$)9*7J@[1VELKAT[S<A,S%6Z<P"G;Z2_:>;9"$=3+F[+= 7HD
MC7UL)%\G"1SU5.1:Z9Q(2WIL;V29#H0#!Y^ (,M5O!M]-HE-R_.#(L\N1^W#
M"H,_BS2OR2="TQX\4 [$ZM?#._@JE-H@V4!J*VRS/7H-O04\JYZO+>9N?-[@
M+U,PIDNO5DE-+B:<?8VN(OSOC+_DT\[]8M#)<Z9(GT&T@&W"\R:@DI-L"L^S
MEE%IA>9Z_)\Q3/YDZZFBDQ+^S=0./U]DS"=M"4K?T.IVKYC-0/3B>UHZV7S6
MC%UYE3[J^M8S/JM%#0>?S:K:.=6>LV<K1.F)-^!$.FH:O,I@(QTQT8]1$P%=
MSJ/2)'>Z_4Q4SP5=)B8^41V#/007D91IE*E;K4RHH4S^O4A+5\PT3H"MG<>V
MM3,<M",QSH]:!L]&FHX"V@N87; 1O0#KNCKO +<)#S!',BG 5$JTY;28%[DR
MY[H>PC?2XZ!CF$#,0R)&LJ/M&P0J-U=H67X<,V@8<B$=O,U6<M+Z#CU[-#1?
MFWB!-L^Z5V99B.HQ#:)R=S^++GF_W7<1V4;D<&#9EW;0DQEVY\G&>*0M5\VS
M%G<HH7U*(=_D/"T6%<A?IH<%F$P@)&(E:VSANNS6*$Z#N_!NHF$9>R(O?1MP
M^'LSV*WXN,*6AT6+ *XCX_B:U]YQ;!0]%"TIQP-* B^:O00WUT0+85T%*\$C
M)!D#.BR8%7$Z32?TW-#$L7F]6)=0H^6!D4DM(U(^0-Q*_R5A%+\HU2<'7V&'
MM'7F U2X[M+SHJ:*C2RI+?9I_(P].76JJ,KYW*-80<D[QXPGQ^7!K 8J%:^P
M::?![590<#AP<YN].S*G)SP)7YU%[%62"P3_IK5:2T&OB+[#GA_LJUID=#WW
M-7;WY"%V=T>F\G"@A9G#9FPEIT@]B[Q*LCY?^OO8G&.R.<FO5H5*:-LO*O)[
MWZ(D6=I:>_3H<:CZ:C'NG=3:1J4C.4ER--CAGZ#^%A-^2\VE%2$S-NF5"@1#
M-4V9/2\B$)!Q;WKB^YS8I,]*5Z8<*P)?* S#==AWC()/Q]\J%D JZ%:)'"-]
MUA-5:F@TU-D<!+DDZ=5I*X1JF=WFI@C2%8Q-)Z%D(M:6(?JR/^S6^.%PT+9&
M^XQS?:KZ-!5M!7$:H^H*NZ.U]%N_.M/F 3QZD0/A)I87A"%(<VK3:$)W4H )
MCR='WVM]0=L5DI"MG<!=40X'>3))J@IC@/0'L25GT1F'/_7K*_4K=$R"#"=^
MJ/U-TG*RF*%M (\2TYHM.<Z2):+50M+I0 ]9$J%?PR=L$51<P._Q.WA$I#\;
M)TG!3%H'Q6.!:?-VV81]C/Y3' YN^1B#[WB*\"0,1FJOIJJ+(N8D95[D22.:
M,AP('QLK!U=9!1S2=R(K)!$IPL%YG<+XF[91):?-7H<<96TE/)>$J5W3&]T)
M,KS)6^-@O.VKDF1!58=%NO8J6K9GPQT8#LR.Q<ANE4C!8\8)6)13=6BNN8?+
M)/,8,^53<J/!M%,^!(>UT<PMSM/8$]9^OI&,E),JQTBW-,<BP/Z(/GT/K<$Z
MK1<U>W[V24Z# Z"E5 J9R2OY?PLP590M'VRLIE6/'VV/E%:5%4G.WO*8/4)W
M#55FS"JS.Y6F=(.C!8VG0:*&)8VMXX@-724W''BT'-__;>DY.TNT&7RTV?KV
M]D?.2*P?X=FIK<[)?!.^OZ*ZJIE)1=3";^^/L 4''[. RI@RIU45<E:2/S27
M8F?'E'5JQ_%\9[_$DE*AA&N;4TZ>TE:VRRR0X6"Y"7*3"_UV][AV @N4 ZA7
M$EK[:37)B@J%ZZ=H<@8^KQ)!<#:Y*05#+J?>D21L*!:J[$JP+*,L\G02E$44
M!]5I<<$/&@XZGV15\GM681FU#=,U+E:AGQ4LV!;Y7(_=23#?UZC)TX>HR9U%
M36[1=0'S<9)0A@:M2!+PQH4!E4OR[$JF<IOG D[74/&)CZ'OU&@.UL%FWNR#
M1/X^LGK*LGJ73:E:2G(DM]1MQX>6A([<W^)_SXH*E24* ="SS<@"2#6J00IU
M(GR^**D7$']/D7*JC6_7BFYO;42CC<>C#B-S S0"*0&.G.OW7L#%P*W#*^I'
M)HNF/P]=,P=\QP+\&+9:[.R/+*4*MA\C+6\_1=/<9X? ATB9X*'BD%AE('%6
M$ [;/K!^4J64,RP</D5VX*8;)KBT5-2Z@><DYM@LB7+RI/EDTRJ89!&%(W/,
M^,-Z* .T_>PQ1N+Z4E@C"=]C*S]5] !K1BJ_TCA[FW$+45C)UV0V5V4-ZJ5+
MDF:L^<]=NG+5,^]6K$S4LA(OJ+C0GOR!!(NTTIQ)EKZ$IV'3F'TR^,)1,]&/
M%(,LSD@K)%\QP8B)Q#'ZOA*"NTBR[-$9^)Q@]R81W!'U?M-UJN+TWH2_]QR6
MY0 YX06W,(]8DDVQI["9=[/2@CTW9Y$.D:/]%%[LTV<;X]'&=C^Q< 2_6"#3
MGT2E%L(D#:O""$B5M;I(JZ0K/UG)2^G;3YX^WRC[7[Z&%O")(U63J,Q2G Q-
M1VQ*(4U!YK* B2TEFE$OBH-%.2<#B57QH1B*2;'3"![!C!R,BSR"=\:),+1'
M;E@"XLG&Z6AC9YF,\->F6+JAP\J^%3;&PF6;CU/%QSWY<S2#5%PVDO\^S!.*
M.656I=8U^!9+M80+P">AYJ[)1#5UHQQU=]3FTW:E@>>-3I:>J0.<CI1--<O]
MQ ^2E(BBCWK0C<5P')!%23Y_^S36D+].1P'5UTGAVUL4B'](^M]3/ WW""X8
M'CY69R6UJ2_";[04/95W&:.#5*7*B;!OJ,JJ\59M*U1%-Z=9ZE0==5K.?1:6
M6S75%1[KKP_WI-%,I?@8I0+%;"41@0P%&\"J%=PEIQ47:'TD*NU/91686?QF
M7L.W\0J&@^_H%JP?@Z7"8,L*<3G_C/=]7P,4SQX"%'<6H$CR$SB.6+Q^KJS"
MCIT"Q&-:2VU6%)\G8*M49'Z44M04392\X$01:=-<#!>T=[BYP*1R&%$LM2V1
M]]%%\/3YSHM'VR^?O>A/HK=_/1S S]MM+*IHT5+!P-JS179B(L&Z[1%6GS.O
M&TVPK#N"1"1X3IF&NQFCWR9Z7!T!'H?U&SC0A(7MOSE71F<.T@LX5!M@]>4\
M41B1DFQ^FY9@E>[&(#3BQ4R73?C/4HKS(A %,Z64;%&(A_3L%;OO:4>OYS.,
M-ZA4C3*_[*#Z?#&&)9X2U)&=3!7 .%^I]G5.= TE[I^NQ'5KSBD(+LUEP-ZD
M;\!4,?A*J@6M^6.T8\G()N,GU48M(921C;DTD[K]:&MGX\).IAH#=)7JIG_I
MGV[@-L(&],N1M9\CO9^KPYUYG].&L1D.T+HARR9>9#9,(9D557 .#!3#!XGJ
M28>#.L$Z! RMDJVS(7FJ/X' JCB5F! 6H%*XE2LAL35J3G8Y&"_).:QJU &G
M93_&/(5M^LDI6&=DF%,P2)8:TD7BZ@V[LVTZ!L,C!P] ;4;6/ASHQ5-Z!/42
M'%>@+$IY,U%9UW)@O1<YL/EI.L?%9$G$16X(XP7R^U)Y%E@*MYAH("N](N%R
M(<=_NSE]JR_F CF4K?8HS0R60F4+MXMBD5%QDA2VFCP+:9-*%<N#;\R23BTC
M5.LE]*,I8;[ASW0!'S4-+C).,!;<[TM-&*662)6?1W&WE45XH>2X[-26[+-9
MYE>4KI!2=Z%@(]I&L<>NQT-$P_,\X>RF4]/EI,Y5''8$XL'AH0_J%'?E%+G>
MJ\%"H@>1C[AD6=R28$[#?\FS7H ?7*)I[B1$,4Z&-F.1\7&9N^ -%9IZ'-(A
M7[R:E.EXE;-A3#KW<-:O<O3,;V!?53@1<0DJ(-8QK P+2 UTA"9,_VN#!*J/
M$"M0_EM!!C9^U0$@N!0VD 38BK(K6$5T@:EYA[(KN6OIU<%WRQD-:/TV.2VY
M*J]YY- :FE;9*-@E>!.V%Q>U)JD*]*MDG03H#$SF"8$YT<;]QDE;_NLJ[.&
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MS-#S,CR$X<!\6S86VSMCA;P2SZ]? *#LI0;;VFR10W 3:K"/JP/ZWW@.7*[
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M$<ZMP0I%C!Z#V9E'3$!4:C"-\.XHVAB!EQHG$9FQ&TL&;;I7>D#W[<5(7;M
M8.7J%L\<EDX)'%Y!C)&H[I',MR''?&M?48;U3@VZBORR<6VBX4"$5_"?)[OH
M5+O88OU,K/K:!K>QL(:#E4RLT(J2&+L[L7(F]A3(UL"*E0PK\[SN8H"&/=P*
MT?OR-XW'Z>*COSQ9SU<::<B:N:(D!H</X.ZPA,JMB_'0HQ68;R]6&URN$!):
MIYJ&J>GY=U%<G7RRXU/X+$6LI68AA44^B;T%*RC FW4%ST@@=/FSII'3+27L
M^VW(B?9]H4B )V:FUVD,NGF:<I3YOD8=7CY$'>ZLZ**7E9;I%X_ \+,NV%$W
M4B9!6Y<,!T:96'+&$E2VL+DUZ6+8N\AM:!5Z61X7)0V%T2)2O[_CI=>28GQK
M-Q%C(HNLP[JV0/*XV#ZR66IP=%,)MI!=FTPLDT,MSBL@^RY^#6WVQ4@V=O-:
MW9#/4SJQ*!A71I.ZPL"W-8RE5'"<7 I5Z8%!'556[H6STZ5!3*B:BUP[)$/Y
M(R4S",UHPVIU$\]30>DKQF)L8RH44Y#'(QY\16F"_M74C&X'SJ)_0L=PT#F5
MH9E H3R&E>!;<@Y<Y%6H 0>Z6,P^!_YTU8VH+G2NT'7@6!IK8W0%WC%)%G>2
MZR6BX'OGE7#536,*1VLMW3,HULW2/[>9A^H-AH/EA?BA*3!IR+PJ12F&?[2G
MDV$X&P1?M(A).IDV(ZN*:RFRHA>T#CW82QL9SZ6Z$$,=>/>$-,*+0PO0RK?K
MYOB06^%P]Q6<C\&_A)<R^ V:,FI1VC.T'J4[-JA]?YJ6U.$TQP0H^NW3#&,J
MNL9E$F71C%*V*GR#>(D$M*<#!Z O%E2/R&,4DEN3<[1"VEPTQF;_.*WF4B;1
MD86<</!!TIH8#)J 1'PE082.%*[W2@R-6&?'Y&)U^XV3283H,!TUH>VF@R90
MHB^_VZ14-A]L4K60NNZ 7AOSKBA>&4G#I"?UPQ4@MZ34;!0+;H>3J@ U48;,
M@4N.<CITW:BS+X$C\I-'5)@8)^/.F$U3+(:J[$7>*_^*$_#FBSF)5Q/H- W/
MM +^A545M4Q -:JM2,M6MC+#HRXNDT1V!>?N,>*([1M]C.UN^5WC]K^C]ZQ_
MH/."JVC1RBW JHTZR;S=0>W"L%#8/*$J-8G78"EK4=84%Z@FIPG&YJO1=?@E
M$.01BCYG%/;WEY1R#-K3O2JU(-X&UJZ>5>=,W#X?@Z_,6]5P?;"<(JZH0(\B
M."'W'F8*7;T?SM?G @E4$ILI*Z-)>W&8 FZ:4^:BKB+V8,;<U[#(]M9#7.3.
MXB(ZTX5$"4(5S2)#G5:F2QC9*=1CFF:(C8@35!4-@1I'%0YAY<8/P@AS&.D<
M\WNQG5L+>0B4)U^QR/LT=8B <#%W 2QMY;I,HO)1DL>ZB2O&@Z#GK)_Q_G44
M_(I=JAE\S%SWCV@V?V7^"%L'ZTG;,21B\GR!\,NKR/JP7VA?I\T2*P!.BRI1
MH*)IGR%5:]!G#I'AP<T3.CW;=[.(D8;YHB338\Q:EE_@1_F[JE!=/VJX'*DX
MH/;E5NBIMBN+T=3D>[R)J;D$!D*U8L\+ZI@,=5LVA]= _R5YI3!452DW-^C.
MHYH86OY#XB$A C_SCT)"^<DEQ#4IYI?RE>6,CZ"ECQ!%77$^V.8Q%2R7"1D8
M^$^XP#-T8)+R'-X8T#_Y&.C+>81W9')ARCRPVNCK9KFWU6JNB!)8%-OCEAO]
MP\$27KM-C[&=^&.LHDE"T2<TLN$/*56:FC[]O CP9+,D/E$?$$(@(C;IA"]W
MDUA]*ECU7A+T,$>\\#LH#*HV;ULM&JBG3PH"2D8GDER\DZY.">8/*B-&G%JP
MN< 73L\$-JJ?9];0GO]KU8RML%TB$ K8:4# #=3+9=<95"J].D,.EGR!U<%4
M%J#Y"80TB=$\"%6U?JDQ*:0(&UM+5>HW=1BD!^ $B$9]IM !;D[#EE/(!==F
M^[V[ISTK  MXI20["B/$EI/:*E$U0CSP@)3FK0@C/<G/?%;5CUO5Q.[:>3'1
M->KV4%#=<]$\&)/6UK_C<U%#7>^*S6Y/>JTAPT:1D[:XN=HU:0O*5]$$.">"
M9Y,%6E%"%7R'0G1+8_;2,MX#_>$VWVEFH8R'!2]#C4U+WR>&GW("5I7K6/]\
M'8I[I4KT\*&VWEJQ/P)/G],7UEE'E+F U8#-P@D/)]('(M4-M%J2THWYFE;N
MYC,,T7! <V6JT:L:2Z/\&MJUX_'*!=^"^FS-LG/[&ZGXHZ/WT.Y@@]^ICE82
MR460G$MI?5!@LS.Z'4*,9+ HX8NUI'-Q3&G\ S;M8(\/R\%[&U[9?@BOW%EX
MQ:HTX(Y.17MJV!'5@#JM7"!7Q^B$J,8NRG"!3@ZM$M[2BH(Z" E=S=G!-7JS
ML32YW9S-S0^^%FS^I+/1NH',91JM32,U]02G:1>'<TKK@O)4%.* ?3GB%5L$
M0Z?O5V6\.*'E[$*B_[XEZ197:UTH'M!*Y(H*[L#E%;%_&FK#R3$\IYCA.T44
M*WW&/HW0-+]<.QKIQ )U\YVE?*L#U*USS+QD4)$VL7]?2),%HM.S[MAHKD/&
M(PDJNTF8<W7I:&7S> V-N,FD"<EB$:H4*U&474, +\\!<&#,$_?7*/PT;P<?
MW3UP9_46;I,0<R=1KMU9QW'SK+W1):W[T>QRSYY#"SGW8> M6.D6<5G!V6FX
ML_C=#%RFC+M$FD?9]*_@:&MI X=[.5W 7H+3),JDC:**IHEJTD[R\[0L<B5<
M3Z._HC(N%L*J7],);4SFEQ4T@H>\]'F198LZDDHD$NV(<8/_WG#;,/3S8?7O
M8?4M^&YD1^(Z#*DH7Q(#;>SWAB8:9Z2_=#Q;7<A,@#,A)>M0VRNP/?Z^4)B6
M#OUWF652JLC ,WKFO.W**I$K6R$)KKJV-2B',J!55L'(*W5*C14QKB6]("_R
MYL+:&P]M_$LY:W."*YTW!E;,,R2]V"C9;)^#=0;6\WE&CGZT%L']OM4J\GF=
M/(<D<3R'1K.@!Z 8MLPE/>(Y(AAU?,(MO*C<$<4:*\QD"'?M%@M6S)$*7Y8R
MQH*&DL3>@J'E=&.EV\TT'=- QO%459^!1,,);A!(R5=R\JGQ!]G;@@Q8&@Q'
MC+7\T6*N@^'*FRRF#9MBA1T4>F9;)Q\&/**<G5FRATLPG6HJ+#8[PD*9<S-4
MB1Z*T+TUTJ)]ZESX6\;# 4U]PNH#:5A%.O^_1>/3*:E%0X>@,69SXF\6( 8_
MJM3]D4$=?>7[BQ?J)MV62!JAAO=["JM/+&'/Q9I8@1V*P%=@(O#M+YM'FRH>
MC/I2!71L3!?Z#NG6,. *I]Z!,KZY$1N[5O&AVE](+?6,4&'WQ#42>PI^.&M5
M<;KIEV:,IMG1O_'&6@,U\SLO]O77M!<3>:J^&/Y\8\]Z?'?#'ZYJ.-#+6C_R
M/#FY2BL95=?>W]F^VSL/89(["Y.@L:>L]""7\%W8S#X9<QU$'$@M4']J*AS*
MQX88XVIN(3[\+*%I,.3Z5J:-$&AWPQB*K'%Y7*/N>M&F&0YWE)+ZIF,[''3A
MFNMT*76V;$B1PFF2@<]#1BZ):X\,;GP7*X9KK1S%@*0,%0LM''7" 00XN_HR
MR))S+,U1C2FHGCN\_U:*E29N)-*.<\EH3HV:2XX8]+V?I_6!$,2(:HY8L%R8
M3T*QDLBVU8G.Y;#W.&!P>CH*/A:]^1.[X<.3=1BYYP4&U&DZ3JF'U +4Q;B<
M^J<4>ZL^;:RX111!, XK3UDT?7<FXQHU$<78"Y&.60D5>0,#7=<,.X7"\BRL
M-KRT/&3;!K^D(".;B/$Y>[IUT7RZF8;G)*+XKV+1E+)>&C'<L;I6^JF]?PW,
MQ\907[%Y1V[2D]ZY^N@2>$BR>B7/<+"NQFFZZM@\PG63+U$UOHA=/XC<#)T#
M%%D@78+J$@0%(5-2?T9.O0JZ((Q:N(H,';WI-)VD$J>6\8.VIX?-S-1JP5))
MQY&<&GVGC]+3N0?'$'%=BR(Z!0B")0<*N\.M-'AE145;+P,6QHX+JGZPX[W@
MVG 0F*MY=?R[HU6A5>B[<DVG)$35D4O>5KXKC86OG%C-!%=)T4\=N^>U\J U
M+N&\UL$U*A%4[\FY92J;\W)6R#I)KX?FPI3**6=]IP?(T)>BVJ8-HBR*E)!N
MM8I?9"X?YJEIN)&O)RY.IU+1N(Z%"'_^:<"/&VS:+CM)"7"<HXP\4(_"ES)G
M1PU=0QDJW20*6EOX$,PM^=+X<H4G^4LUS?PV:]RA><2>#/W9Y1S']LLG6TN&
M'7I_VSWKL ]DTN!X"L8++7'])//966?Y28>:$EJPZP= L>O"80V[CV"H%@9O
MP^-%.Q7O?J69&A)94$$H>"J:+76E)R5:J18R@L&K%YA-N.@%L^:4M7J1-Z=/
MDU$=MB(@*N)!E2O X@A( NX&'D4ZF],AP?H%@E7,!0UL(I?.-8VUN/."%DSI
M <)"0:LC^KI^1)'A8" .W]/1::@C GY%:1:CRJ%DD4$&4E,R?R,%BU&_M*)#
M;@*NJD)9NB*!*,B*,>*DJ=33AZ@\2VHN774#/W28C)?:>+\ *U%\-J*!Z>(?
MV6CY0"FB@>##UL(T[FMD[;X?CG8-)?ELYL+8&[&=*[-VVDZ869^U,C+L0A38
MM%G@[7*-5DCV1ZM$ZMY&;1X_1&WN%%/%Z="]9*0P+#>0!LQ*X/; 4..&(8;=
M:T6%?>CI+6KFNA,-'L!&B,Q#/RUF"L).&=?HU5*!<5%:KK2-!L"=LA58JF*4
M@PC,5>>)CO+:#4^-!DD2B\0@;Z4L>I=-S#TVB730&^/B^RBR:E47CW\^1C-T
M44K.V/.E(U5UW?$Y6B1).4E&NGA3[\729]8V/K)%0^4&/#-G#['.T\Q(WCD8
M8_AU3$#] D?^(?H3CE([VFK-)IY/#_X5CB2&.]"J5DV"M8_7 )G3^$Y]C+ME
M- [>)]')(EF&/WBDGM8>FLN^> -A@HDDQ "=[S&P\D_TW99%F)L*U96(4Z>R
M0FW+,%*XFFK9'A2)+7-@LY0\)0GC'%1.KP)G=G$LTH(^1_H"&M-E<HJQ3#PI
M3>&&"\3_B6HL0_.\9X,#G";>1(_$4J6]Q3@*@T/8=!@<78(S%()>Q-K47X'*
M(VTLKV3GF6HGG6_4[@(5D=%1?#G#I&#2Y*^]$J101 #V[ ++]T*V2I8NH"H>
M32)\DWKW/EQY79W!I1?@ 2N:_IPP]'^XVK9:3WV_  NGYZG_&\W1L3W]ZS3E
MT_OUE(ANU#$EVA#G'E]<@SI?<28L7]6S(] C>R27"2 &8%2IXA:L:M;.CAZ]
M[K/S]6 (3(DG/*\ZYR"B*72CV8TS\)P5"FJ6. 74E<:5T:&X,/BS &<C.!>$
M**2/G"$IZ)$4&6EPMN[3QKE'7.$A@1(A(BNUS+:[;D5!#OG)JBJ"M;0$PRNG
MKLWY@EQ.H-,']B F(P!U%TRE\N,<VH=_8]#_/,H2!6@5U6[ 42;$8][,KAYQ
M8TRC5XVZ22L_8&V]5*UM(D X]'A"M2IX4W@9;KVED3B>C&?HT%R3Y#:#MXL2
MEQ"J@M&)MB>EXP?SFKK6@@8?""( OQ\7!MYF"_#+&82U378QUN5AHS%G1^B'
M03JUR_WMC </X*T**_;:.36GU/-[IJK)@>?GX!\VI (0ZT,B(G6J&>42AP6'
M]3BMH^+M@D_:@B[#HY_4S@!)2O+KE\O% J4J?6W/I=\XV*/,P\[.\^T?7S[#
MM>WL\"\^@O2=C8$2ME^^?.9$2F3QA"%&Y"C5M;AIJX(6X8-ID1K%RGJQ&L_#
MKW &NKB6Q"@4$I6-=&QB.%!;@(6FE&R:,:HK/A;,"S!$T@FOTFM]C/'VRGK1
ML8Q@XP_@^+B,+B+TAN'(=[:V7S0JZ[[\L=L0MWA6/RH#2VHH$-<+;.O+"9C7
MM""W/UX6M$E5C0W*QI,G\5E3)H9'S'31-HU:Q+BJ4/CXTB)RD9\66[H-UVF^
MS 3!_WXK-1U*7^'?WR58CGYY=?YQ)0@>6J/]D\0$/7TX4$;S,778VL2PN_A'
M]1>X.J^2_ (N%$=U3^L*+(FBC/-%?K+RG<A&UM"CS_-K>O0ZC^MXZ!YG3'GX
M")+ 'G[(#IKQSXR]+HKU)@X:]?(;;=IVU91EVT>1] 9"=(!C-*8T7"7;H[8A
M"M_]<!GE<$^LC;#G*7$F=X&G0[_G"0:BQM[J/,HNQY^.(S#>WK(DM&7!V]WC
MMTU9(&6$O\'!HM#;V=K9"3XQWQQI)+G(K10/\$&("9;AP>+/661RI)G/WUDU
MZ!:5]R@H;@5&1GZ*&968,O,Q^-,X.2BYQ_4T3QXB,W<6F9F1CYYP6AP[#HH<
M=;/J$TXKA#: _R%8#96 MREPH^*D"(K8C7&3%LF=3,I'^C6<=:T3KOQ6R5KI
MPK/2EIS.U6\L<JXWD2 NUL-CO2>L'^QKM$9(/*AO&*L>91*XL6 "5S/938))
MQKI_/^1L-7PMXLP6__ZW]=.F[^5:,CH99KNU\(U9]">CH6OH2X\\;,A!CJ@M
M%X0B3WI7O=GHIR 7$'7U6KJ!$HA;V0_TJ)8BF"ZD-LKU>K2WQV?:]/E6.,NP
MX0(NN\<5]1F_>CA8\NZV;W=K!'>EA2ZCM[4SL(JB-PVJ>4,7."W%RTM5AT K
MD]J/UI)_&S,OZ+/R=!#^9C%XS,1Q-0059"GD4+]4">U(@]])<#&!M=BA6+=R
M#_:*$F<#P9'BZR:"X$3I_^?/;:=V61[?).W;A0)O]SXU_3X5EO]U,WB#(9GR
M4OF,6R$WV9A "[H>$UZG1 [8&Y'?M1UKB2BTC;^&ST6GP]_*I./"WA*-Z-9=
M6:\"3_55ZPXI [L"<>$/K=P-]Y*EJJ&90PBZ=F@.K#-1[1LDVF,R#2RDAAAD
MRDG.:5IL4RRDIA>T<IIX.F;(5H=KZ;F'9CWL75V#/=?[/JG6CB4U.ZN[3WHX
MT"0?K"/%KZ'>F<^YF=7%([4+19>TN48R&\' >EI@2347C=,J>#;QBOW'=D.L
M5FY<4G>6)'-E9?M;E,/ 3LP4!IZ1!/4>I9 F')JR@CJFW/&S?JH1W5M,;1_(
MUG^O;?TP.!;;OE:>NBSM6'4X8;_TVP76.&\<YAKC6]6=?(HNDW+D@*0"_;*B
M4!%/^L=%@GW"5;-=N.5\R)AQSMG!=UU7G;M%KW"]<IEV=_Y**DM$'59@<?EQ
M85JZZ,>A6[16!B>+%!N*\D1A?(5NBIL,0SH/-ACS!ER-X3R"^>)9Q8T$K8.5
MC *@>9^^[N1 D%>4^5 M&)#!FFG'[6/LRO.V_=CE[AKO;33DZ4,TY.ZZBTYX
MF*0945;(O&U5XE>.TYIF2 HXK4H=KF02-VO)NKF RZ5EO(PQ\,=)5;=DAW@E
MPX&VT&Q,I_MD@TB6",B/5NCI]?>>V'" 1[9^A93__C<FV_*VP=R@$<=R%J>I
MVU%2<0O,_-EV,E4]LI 3]XFN0XV)J:Q91K'Y8$;C92S3>YQ0S_A$BB3-CUCW
M5%Q+;U!H8.OI?.$:B/,R-8A$E:H?:A0?>#IZ^^EL#0VX$JR'XW;B*[5,C;3=
ML4?1$?1R=*"!*!GX^.GV*R?1^86RM4]?/OL1[)(GX$GFA#:+M;%@$B3=:5KE
M[%C&"NCWA,%>_%:#9;CY,09,43N.SI)G?7:L]A>L$3]$)9 6+/D9C0$P:>'F
MYM3.E&0\B<J8H3&4GAX.ZF1RFJ<3CJ_D,7RC<B!U!>3"VBD\8&EESGAQ^6@<
M3<Y480[(H),RFLW4] (F\XK7JJ/7K5C D7P/-J<,%_Z X:*;QHP8*97Y56/X
M1X2A%IE/P<$3CQ D/HRF.,NC'+,MA&U,*E1',M5:&"]%!IS9I*D+NZ,8*!2N
M$XO#VL2YT0.5W7S+.@ZYJ"KVLBC7$.DY,Y&*S27_HCY?I)PW*@)LO)#W47ZR
MP'"=D^_[UYO/[QN7J^8SLW3M@3-G>?'9GBRE(Z6A#+E0,R\4XKFY-*XG(P[H
M].)4'W%KT(-OX)YA:SWS1?L7EEM@\Q>/S5W#JZYK.Y!KK(X5.EO"5EMQMU)<
MTL@=6FV#RV-G/ ?IOZ-\@4VJ7- 18K9XRQ[90U>)N!Y*FW+%3TA3#_3<&>FZ
M*TJU8\+V,TTM6+99S%+CE(LRYIL/O79EJ,H$TU*W]" +V9:MS$37L]QT]9I-
MN23(BZPXN12 HAG.FBHEUT?![_JB(&AU$&SQ181KKXIIS?^%Q2&<H4>\3N1?
M@L& _QA'5;O@VO]U>SV^5H<)D%(QX[FQJC ]' Y(BZ7TYW.>::DUK/,>PIN1
MXBU\9^A 2IF65?2OR>JM*O'.X;R3)A9)V"05=0]!QS6$>E4DZVG7G:]1*Z7D
M5S/"KU;0*MU?M@2NWT*#AT<Y]<0 #D%!\]73LO=AM:T,*O4.>["P6T>3+UL8
M,6T_MPF/<0D(BO, 2Z58W86F;EP!G9$4:"#;T^%K4$0#O>ED-[K$BF6X.X;S
M#5F=91"<C.? 5?.L:3W&:FG_(:N,0<\98SQ2-!?'CK5N\H&V62I%A6]U ,T#
MSG=O(S;/'B(V=Q:Q4<ALE<PDQ-!F5V<NBVL)#5J1G/Y H=6+HJ$%= JK(2ZO
MSC!Y3-"_-& 6)_(XP^L+"UGF1CQ)4+M-9>3F4MH0ENEY)(%ZVX7W"!&[?MI%
MOB0UY/L%EMZ@FV,)-/9G2:J!H@372_?7>\84;%[7S+NRE=<]EN"*MX)61$,=
MF9II KRC#JV4X!@LU(&B=* &%)1%J(DPM)*HDM=6EA:[S> J@@N#?K,=+S)8
M#IR&=6JR3IC@\65IOB X4I6C:E%$IW)I.PB&V9\9>=TIOAUQ#8\YWGWS_D ]
MZLUOG_<//C\"X?9^]]/1P4_J/WHE2%/<_!#P8_[YP]8/P=[!^_>?=O?W#S^^
MT_\^^K2[I_YM"TY>SV<6L<$_@Q\LH9SF6!#S4W1>I+%\<5_]^,G?S::.]QL?
M/@6!_+N(.#@4+>Y8T(+1M+-) 0;KE_8WG-_:^BUP#SJXJ89[%;0E,9IT$OPX
M?/UI44Y.2<8<*4B\?0NNS@KI_?SCH?I=P'O[Q/N#__,9_P]>^7KYF-$H.#(5
MN\@P7M!5"<>!6&6K9S%7 [V=&G_^(G@X-/];@NDXBC6IAP,:\]"8LMQN>:?^
MF(J;3!IBB#_1P6'O[VE(."7]A+,Q:2PS>^G+5M. 904W/Y*7X5BL<X4ID[.(
MI0H]JO$IL/>*2,,47[86-!R8FKL::]/43W18^>7+S2? A5:X&7%J$/)G1M .
M-:,O2+;4Z,76%^4!8/Z_M-<A-O&W7L3C[>' K,)5URI3TOBMO6AG-,A\7E2I
MFB70O"L5Z,%)9?B63]@WLTNL*9-:@\. @SR-X=JD5,&CB\J;T*#G"2/P-#O)
M4+[O)\3VA]<F1=_.[IP6AP,/,3HK^6[DZ"QC)7J$'[M+[R3*X:!]<5ZZ?..E
M2TYK:L1>]7YL>6B!=*BKU/=,0*U6WY=\+572-YK6U)>.B')L+$FGIH0OOKQ.
M\%?N)6#L(K1ZS.N.]1&A=U&;=XG.%Z^PR)A^A^L*X%_MU6[*:C^;<9Z5&CFN
ML%ZX@QR3$30-!U95"DJ7/0*$*V'?)N/2A%5VGE-<Y3&8U?4%#1M7CY%M?;84
MX;D(CQ]U&,<D14?M4D4;FL'RD5P86=4W6B!"$7WNKM\MF4&L8US9WW8HMDZ$
M_K?M<&N+R]G@J'9>O+(^XS_(%R([/DZ,XF5OF8X]47CO3L<JVA&T%,J FH1!
MS,N$9[:R3\?\@[=)TAHU?NPY8$L<GLB,$XWHR(+9/##8R!.-D40@X@X>/<&<
MCWB:+QA\X#X$)?IU:,_12%_:MH1BFT#.IM5$D4)=T(03S2T^N6(5'-#,,"5,
M\/<D,%3IG-ODZ!,=]S:2]/PADG1GD23;0Q$\6Y)M*M=,BL(FPE.,3XX3%I4@
M)5_^M+451)NSS6#C/?@!:.[#6XE)*"'.%/-2I&(3P]OW2A'\_2]]S"\%JQFW
M]S]%>=;W7A)FI+NQ,K!DF$U1'"UY02_CF %^K25_!(^SD?EV_XE8G:UJ>1;9
ML8)JIB%ITA0/7%W/"]68HC6,D2:-5393%,TXO0T\$%4F5XZ2P6ZB?A%LJ*2)
MM2AL)E>7Y+LAZVH8LUA$M61IFP>F:<QS*IN.C[R1-GT^#Q7@]"E6TWOPP4E9
M+.8*2XTAU"II:P]VW[5S/$VOH-((T&J7\D6/L8.7<ROO#!O6[2IDCUU@[XHL
MQJDZ1W#35? FRL_4:X\.VJ]MFYJ=FV6CR;/=&[]Q$^N--?6L=,%!0K%&!"/G
M%-CX<CBX2''VBZEP#M+9+(E3KM\PI773A4 [1\$8%RNXA^P *!#$. &++.."
M&IG!QH-E"#E/6$6RDFV#NF@V*MFF=U.:@+#*D@@.O+XH3*M=#.J&*A-B/<:.
MCL]F%))9N'.KWE_F,\#7U?T!<XL($<-O]64K^]*W[BL2:/O"@BO?E\&HY%39
M<$ 7"*>$5MV>A%V5M'<O-%\0PH;:T>Z;7?4G/>Z8'N:_8I]+TG7)\MU;OV:K
MJP/EVZK7O-+2U;'XU[Z&!2UC+EUJTS #-?'Q745N^Z0-)TLHW$@(V@7#\\^P
M5&U.J!CXT!,6\O:L\+9%0(\6=6#>X/5._%_EC8W15V/[/E;-&@ZM!(P!*DD^
MU:4@61_E#4244Z&1A/0L I''8@%\-0XW*DF,#P='NS]^_+T![J*^XNM'0%;:
MPP_!>4JB&3T%E?_1YNZF^QCK6ZU#>)/DB6"E*MA</7ZF>47J5*K3X@+;5R3/
M(T+%#*A0W]-BB!!AZM,2,6%":>*AJ96I-0MT7!1GCQ)"J"(: )8R1^3NM>'K
MKG25;*LJ01<&/#-+3=IP3(.6\,6C!@=NPI,(E&S9>1*<%N ](U%;$LFFD#5D
M9AD3Z9-4J["SWS+QZR,&"DJ"6V!I>?@RI@Y[&'$OB1/6GO^(9O-7P5ZQ2724
M%S,@05HEGPSS*6;=CW'ZK ;B=GAJ_WBOAY>P;J?!3.WCN5UV"I9R$RQ9=WA1
MS14&-ZAH854^N\?P+2\>@A9W%K2PY,E-Y:_?)OJ_)8%Q>"RZ]=I<5Y92524T
M/,Z)RL@Y42" G/\L H$K8RA:\5L'IP]Q#,&@8F1#JPY0-5-953X:G\[R3==X
M9$ R"HZ*#%V7!IRFVHF>,JF' NRBP ,/Y^7&"SVG^,/AV\-]A+X@P,MW5'Y%
MG@%7;W%0_N"+U6FR3QU0F++"'MT?G[Y\W-95GN=Y^S"XTT25"L\65'J%2;$"
M&P'4 $E8*IS!8HJE625>BX%":;]H.* W_73+%_;DYM-W1MT8]D98_'3;S+K]
M^*8K!UMZ>8@I[(W+A,&']*_%J6-*RX?O/KSYA;CZPY>W[S3*-<V.YF^,@H^;
MOV]ZH:#H[( X/UC4X4&9KHN3I%:%R\M^WVY\-CBHE<Z$<_##]WO.U*4U$RFU
M2BETV0998\4ZYPRQ)@7LI;J7L)F#G/I .[PZEQ^H*:ZJX%QP]G"*1JV;UL3]
MI@00ENDY \5P^$.>9)6R?.QQ84U_2*.W2(.[7==/V:%%K:R_3UB"@Z.Q0:);
M4#ML'YL_;$IPV=>5T\(.R1&5U!FKU.IC;*R8*6+M>.S-9D>,S%/(80?)'&UE
MSZKSDO:(,I]\XO9L#2&A3IICR!=37^^G*#\166".*]"3'2MLKOX.B"V\6V);
M0\MK.@K^Z)VD$JXD[%4,TY*#3N%/Q19(FT8Q9D@!0SW>>Q+-HPG&4KE&I>9"
M7(Z.VH;%E]='YE-4+RBHM=.[2H:#K<U)P:!I==*X-X?O4+KF5+!LK:E=JL+%
M'_1'-148G &X!0[(-%;<T"4RM-Q^GBY*;,3-.YR*-$]K+E1&&&M0)12HFY9<
M0J'B%FXLVSU3TW4887A\E[]D':TV+\?DVEM3I)RM";X_EV"BQTY)#.G$!+5-
M?4Z/N"-KK(($P)R3C*K1*+#P]-7/AZ^!4'4;^QP\&ZS[+Q<I%C1P6=(H[+LW
M2:'Z7Z=;LWAU:NP@780IT).;U?D7\4.XA(6'HV'C&84@)$2$H\V=&!$6;2Q#
M;K KGG+A0_]U*%)HDA.5?1@WJ1&NHOJ/>UQD\?(A7O'-YH*/5A17K6SI<'!5
MP:5]?AH^)W1//4,>QC!<;2EX)3,4R'XT+LX33WKPBDP(;FT"G*2CIAV\J$H#
MT5=QCTO%>6AC?H7D[ K'>V8R/Y%B&R2[+EGTJ$FZ2=Q92*G*-.GP_ I' QA8
MZJ;W6/KW+CL$.7_5Y3G)UFF19<4%(Y;!F<]KW:/DK*U_+1LJ T36+#9YJ(QF
M7"S&-;:B2FT-&<3T)&MN[3HB))QV91D=1F1K'+NN*I]B[M>TP\%55&VK-/)-
MDIVD<)I[Z3F0[EX1LQV''U$U<C$UD72#[?E^\369C>$-)WT_=*+N3HTS]6\X
M,RS]-/'0Z'3+C4Z/[TFCDXRN,8'?9D=HVX_^-BU/-Y('OEG=&S*Z2 L^L^-F
M)=UC;)'"?3?^.M>%?ZAH>"Y)JT9'-9^3F>NI_ Y5"X=TB4A%<QBH6#LM[+:C
ML+?2-8:1V.." -:L]LYDBLT1#&U./:%-3R\V$TOQHY7FJSH_6FW6*DY&0KO>
MP>&=,XZR 0RV#)V>G9C>4JXTE;&J/'T[R H:L*T0T(S#;AP@,+@H@@F_V@P.
M6W;,)(DJY27APTV12,?N+%/(.JJN&;+MV!?;CMW[Q:A/U7*JB]SWUH#39?@#
M#@NYO[#"&YA>/F$0=G#])F<X/HRWA= .<\4$@IK'J!.",$7U M:0)7J_'LZL
MG<:\L>0UM$W&Q#0"8J3"A1)&8XAP2K)S^-DX :TTID@>%:7F&\66,,;;LHB>
M9DB3*8T#I+/H4L.%%\$T5:"%UBIL8P4#E\&3G2>X;M7GHF.9-M LOMHR$]LH
M3-3)CL\P8PGXNJH$\XD&JVH_LBU;2F>JF%"KRMQ-4[["5DN+H0F<,2^,+$5H
MN9F F3"LC$)SZX>Q"DQ*V#HG&Z&'YU'YPZ6CGJ2R&J&'I=Q)*5*. !NDJ88+
ML%\YF"8XLOH\Y>;#X:!%&H:;**J6ULHEHUN2(AMNGE.V+KI-%Z>,;6\=4_^A
M:!PGI**X^TRM(U.PHX+Q9WW2>)BBST69I]5I.Z.,1(U($_,TT>4M>$CGYHR(
MMLU99)D@/+< #/F-#E:1#T[,X0MW8!F:"&$ _S/!_WF"V]Q^BMEY):B5H$,,
M:(1-P%(%<T"V9+..1#EF5:%U#%VXTV:!.]3BP]K:?0U7[6P]A*ONK+QF*49I
MZ31JVNF^C7.?]&GKI:L+'VR2II"#<*#%<0IR%8Z(PQ\T?$+!Z5,\!%Y_+FB<
ME$RI#,QP4!"L@94F6U0>/M,+X1]75B;OWPNXO6DCO6?%X*9%V3X\L5]LK'2S
M5THT* 08A6HL<329LZEPP*=:H&)WL52E,"06?U<5/+7/37LU,W,8+G*I[EGM
M5'<MP4WKB;GPAVI\==90;.ESI: 4$.6Y%<G7M]RZTZ#W2K%+XNIWVJ %#2'G
M7"AUS2\J2TFD=65;Q 1/;9G%Q9B<@%0&"_ X30=G-IV":8KE C3*"2X&FWYI
M 2MK53QE>,@%UAU97ZB<?.J"XF^XD.8:R>>BO3K6#CPPZ'A>G$PR M3DJE"L
M2+*\)\ME6D-K>N)8TQ'-=\@(P 0LXB2I&?('+HVF&7"=5R23AN<=3*W<)<W8
M2F"1_%S-/F_;UV9-'OOZ\6/+6/#;UQ9H+5EK6M&K#A/\V1K>4,R! E\,IAM<
MXS2J$1XP0W< ([+$=U6@X-Z%#_&W;%FC55A32SX<E25TEO0^-=NK>Q$V9&U:
M:7;OHKE\-&UYR8)4;O80JD2K-4<Y;&\L:.S+&56$SQ\.<*U<&(MY606*S_#T
M%)C@)GP7%,VB>@O1T6"DH]P2@_@M)L/_$/Q(5]!:/S789?9#)$U.^70%06G,
M5JDPV\!19<E459TS8VP][>6*D2[.[+'EVS.ZO=8].5UR2<M^S_5EBG=[EQ@&
M5C41?JLIH@R@,=G[M/Y.3P,]C.& ^_Y?F78WG9/JI1J%CLH_-PG$&+UG Q%'
M7IC,$F\E##K(('%'Q!F, @52H*N $D1/+8L\G01E$<74LG K8NMFM9G*0.B@
M47640F=^F5^42P1#!]8)(:A@ %'XY),.!'2<M@(Z.5XN3)DT;,2M2[[EFDS/
MV(@+^H-?'I&<7+HJCH$NDQ>$$&GC+\EZ&%#57A#]Y=*_(LW S=ILYL'M9T_H
M.<N8LX&R3R&<9=NT!T(U^ .H+-,FGT?&@ 61)2?:)HVEX2:0*51K61Q_;((P
MVDP6[>&VG^<R7V,!C)(I#V0X<$O'WH ^*H,/DU^3_*\T"=Z__T0VLW@R>/OW
M-W"Q_1"XN+/ A<!\HA<:36CT%YC5_+=),;]<XLZB_56F)ZAXF3^3V,N>!FO#
M<M9$?_7\RL@#KHO,>=(!/>SK:3H&-VTXX-_3T_ AZ\?KTU%P.*5F*A2#Y&,X
M86L1:VU7NS]=('TD;;/(0A:?3+#SBC2@8(;KRD<*F+=1;]G:U&61\*A%7I>+
MQ')K*3BJ\;JQ^IG"!R#<<:'T/?JA^Q7MO0<J?T"1(3,)MQ9$%/$_,IHW)(<R
M2<O)8H:9O@EF?ME*U/NX#"YP^H%"NC'U2F2HIU661!Q$L(T(TH2Z6HS W"\M
M0>RQ0BH!.:-#,;$1SR&B,N74(U=0I=SG);%Y)V24Q*]LR#[\BOL%OFK/2T@G
ME-CJQ#NN[$!'(3S4@FVG!U\VLA&-%WJ4D,K0_AOI4;SYJOTUW+B5(!/MLX;.
M\PGI7]5'O53_-I2O^P6N"V/L#*$)G64;#N("*)?%EN? V%5H'YDU3AR[<(IR
MQ@+9@A*_F4CND\@;3FU3\E4)825S1YY2QD9VA2<Y^PG>\]VN=@BSRG[CE[Y(
M!@]E?59)X]CBV%,DS^V?5POKN\UACC'K"#"9[TET8YG9"JX$9TE5K;Y14@#;
MSW?ZW7;.\T]=,:@5@J(W\@M(.932]>)5#ZX'4E,6TW^EPT%3;]R^VJ""B)@[
M'WKT1[A<@03=^B-LZ S.W3;S^(A:J(ON0YJ[F$[UBX%+<PF ]LF-4.<A5!$'
M"@'4%3I^X.C,#MW0J'+01\1.GJ%9BS1W"92^"$3I=4190XU$G99*+(54?:2C
MPAA6$1=&S8&;G&+;59\C0_/E&5^3X*M->!CU!TU>4&(NZB0X>]=\C^+9+E.(
M-'2&PO'\)6O<2)="XWIJ8"0&9.48<5O''3>-"P4F:D QIX1762LGU?2CF<"A
M>V*95%]K);*&JO1T%.PO5#B?CX?,I)6DL&(,Z1,RDI6*]D2T&M+%,I3O(59#
MG7+0IH)?IZY>X^'-!'K+/(8#)Z7:EW(*^>AAQUH:65DW-0+% WCHC>F/W61(
M6XKH&#5<Z;V-+NP\1!?N++I@PD^M5/KZ^>GI" ?-7Z\HJ,-0;(FUSCJ0[V0O
MAB84T8BN#@?7$VQA;YU:V%'FUU/CQP$-I0%[YF7JSNJF1.V5ER8*&U'$BTIM
M"=/I6LX@?L'*HBY+F[+MHKYE:DV=.M-QXBLU74-3X$_RJJF%7I)FTBCE1:L_
M<DP_@_[/UCEG;+YPG.63/$C2,PA:9D-+^"E'9VYL[(9U$SIG('34X5"UHB(^
MA@YCH6EUA86<D,9Y&UUSOSDC/151$_*$# 7(KL9?S:5F> /MX9P1T,4XMP8-
M,[F=8W&9]$L[HZ%"GEV(GI\[$BLT(PIY9_3"5#U2(].-.1(U!\Y!*6.YY/+#
MZ0*A%6"AHY JU!3( ;H&=J<D.Q7CVO8G:$8(<<P)I^XL$%!GPKH@L#:L(N71
M+,W^KC\X:(;3P5D:@^.\RL3XX 8#XX>#[S4Q?H5;_;\P3'XV CN*QZQ9$!$M
MW>*6S"EMM4KE)4EIYA0WSVCA__ @3NF*M4LR=:"S&5- <\7"B#?*_[^C><0!
M237X@^HOR/3!MLLHCV+I%'/[A9R]T-TJU][8<"U7LZL.UZWY0!63%Y)'8;UL
MD]%80[,Q+?-**$X36VC&GHI5,>8X)8"B/"\N<+VR%Q98PJDV0UJU0)5,%9/(
M65*>"T\(HA)'Z].Z62*#(C\J>0@[2K96QSG?/ C:YNF$5]F)6A[OPRP6]! ;
M5=%7)K[.9U(IJ#5ZT6BN<:(?R$^"LS:]ALV:!6IBF8-,."FC^>D:<G).!A-=
MM82LDCE;0]X0H "^$"GD?OF6MTJJZ%'#P3B9%!0+%LN*<4+(I)XP>*H85U8]
MY"R)5 FU*;4T(N#0/$+AKV)00*,@=8U7;41-Z@:(X5K=4$$W1/%F*Y)B1G#J
M"F&5';RW<9#'#W&0.XN#=#"K@3"G.D&J\2HC\&5(LH'R)&RR->2*N6Y07E+8
M;T;YV16Q5%#*"!&BF F/@:/PU*VM0$+0&S>.T#2:6)";^\=[J\,BKYWC]V\Z
M0AFBACG>M!34%E@UED:K2.T*TU.D=:(L,NXP$$,:1;<:P>8'X#^ROOF!O]E"
MEY0BP01'3^- ZY1F0 M49)9(]PIH7IK'A9W+$VO2/.[ :FCAC"Z8(W&FPCX2
M(QP.*$A 4/SSA"9-.P.U"1ZLC,U@> 46^VSC*97$6!K%8,&:6%>P<?!EA(BP
MSW[<WGI*8;$7+&<_X.PC^J31RM/\\<=BDW_Q].6S'^'[3^QV\3GH2IQ#F*61
M;B;1N@Y<UC13Z*J(*$MY-&MV. UBYB',V,Y.,YB556//BG6J*L>+RW$T.4.S
M#PP<F2SK>E&@P?$6*@M^WW/G]"JD( 0Y5S!LE$2HG='?II$6'7>S%O(%.*,E
MT+MH>IXGY2,P/0H^"[;,!9@GFIC>"[CR\Q08A6S%.<U[4W"[W).O7;[ZM 5@
M2#&#( ,S/0M.P=\TQBY:RY8;:DQ(;(**TBPDRQ%G%1;<PF(]WG-";)!A1II:
M=_34.6EFH"F"5DS ,ZO6.V,$&0 8I1+7FKK3D T*[I8H:DU+[KUJ^W!<E+G
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ML!0 ]M"_ H.7@L(:GD*]%AJ@KD'O\!F2.!%V]XT)!HBK;U)N?2! %J5V@3J
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M49!?ZK-.%FG&2>YI&2WB18:_A^^Y0UI7PF#>WD:T(&_%_<A?9.!$IG41AH7
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MD0\U+B8+#>17EOBSF8+M"=7OBSF< 3>.6@ K_4**6K7M[[HJ*%0Z5R,I/I1
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ML%$PCO(SBAH4)3XP7<Q:NXF3219)^\B7G :VT6P/L.&2F K>X?W6+5#?F*R
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M%H5XBODV>VBWR]Q_QK*CA#.X;&C0>]0!8PK&B,C/G]1I-,CIS'8PX]^$,I/
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MK[T'5P!L8"I3Z4L%2.<@Y7'3'T\&8 5B_9%D'A= B#9GTB9-N@%<-$*^ [C
M40( $83$2? "+JQ"DI_@4$E0V@DB2OD1D*".^6P(EG\T:OV9PU,.V ^+U2:
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M/R*VPJ+*K%:IG$C.%^9D.>8S0Y0*E*F*Q8@"V>Q&1+1JRJ6DKYJY 090L9F
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MF=:.<L*T]B<5%\'(QB/Y2;RH:[UHKR=29$+-AC"K)"&,_"KZ41,D7$9.3FW
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M.#]+3VQIY]5'=O/N/Y@,OZ !#K#T"[S@.L^T8A3R15(L-?G+-1QS)F=D-Y^
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MV35H7>G847'T?:])[LR07J 0("=YP ZLR""I=*(%*9U9&L[ -8@=8&8V?:R
M[W34R@W>(QB\?^K(/](?X\WC3A=8H'=8LHL_G$*:W<?BK+X'/%%=]@H,;7=
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ML08$3A:+9*%O&0FVK7NY>#J*49J.&36$HT3C "*%^GL/PHMGU!M#)X\@=^,
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M^0I02P$"% ,4    " "!.&-6D]!2J$<3  !"=   #@              @ $
M    9#0R,C$T.60X:RYH=&U02P$"% ,4    " "!.&-6Q.DM]F>D  !#  4
M$               @ %S$P  9#0R,C$T.61E>#$Q+FAT;5!+ 0(4 Q0    (
M ($X8U9S]SI,9!4  .=(   1              "  0BX  !D-#(R,30Y9&5X
M.3DQ+FAT;5!+ 0(4 Q0    ( ($X8U833TD[/@,  $X+   1
M  "  9O-  !T979A+3(P,C,P,S Q+GAS9%!+ 0(4 Q0    ( ($X8U:T8=(<
M5 8  'E#   5              "  0C1  !T979A+3(P,C,P,S Q7VQA8BYX
M;6Q02P$"% ,4    " "!.&-6I;^X;ZX$  !E*@  %0              @ &/
MUP  =&5V82TR,#(S,#,P,5]P<F4N>&UL4$L%!@     &  8 ?@$  '#<
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
